The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
| Ashleigh Tuite, Victoria Ng, Raphael Ximenes, Alan Diener, Ellen Rafferty, Nicholas Ogden, Matthew Tunis
Vaccination has been a key part of Canada’s coronavirus disease 2019 (COVID-19) pandemic response. Although the clinical benefits of vaccination are clear, an understanding of the population-level benefits of vaccination relative to the programmatic costs is of value. The objective of this article is to quantify the economic impact of COVID-19 vaccination in the Canadian…
| Ilke Akpinar, Erin Kirwin, Lisa Tjosvold, Dagmara Chojecki, Jeff Round
Many publicly funded health systems use a mix of privately and publicly operated providers of care to deliver elective surgical services. The aim of this systematic review was to assess the role of privately operated but publicly funded provision of surgical services for adult patients who had cataract or orthopedic surgery within publicly funded health systems in high-income countries.…
| Wendy Sligl, Justin Chen, Xiaoming Wang, Cheyanne Boehm, Karen Fong, Katelynn Crick, Míriam Clua, Cassidy Codan, Tanis Dingle, Daniel Gregson, Connie Prosser, Hossein Sadrzadeh, Charles Yan, Guanmin Chen, Alena Tse-Chang, Daniel Garros, Christopher Doig, David Zygun, Dawn Opgenorth, John Conly, Sean Bagshaw
Sepsis is a leading cause of hospital mortality, particularly in the intensive care unit (ICU) , and the related financial costs to healthcare systems are substantial. Antimicrobial use in ICUs is considerable; early, and effective antimicrobial therapy has been associated with improved sepsis outcomes. However, up to 50% of antimicrobials are sub-optimally prescribed,…
| Baruch Levi, Stefanie Tan, Husayn Marini, Sara Allin
Emergency and urgent care systems in high-income countries face major challenges related to overcrowding, long wait times, and rising demand. Internationally, and across Canada, healthcare systems have experimented with various policies to promote access to health services for unplanned acute conditions while reducing avoidable visits to hospital emergency departments (EDs). This…
This report provides an overview of the policy levers and associated actions to support achievement of the principles outlined the Canadian Heart Failure Patient and Caregiver Charter. The authors hope the material will be useful to inform ongoing improvements in heart failure management in Canada and support evidence-informed policy and strategy development. The report gives specific…
| Don Husereau, John Sproule, Christopher Henshall
Combination therapy is the use of two or more therapies with the intention of improving patient health which are increasingly becoming more prevalent in the health system. Combination therapies can be produced by a single manufacturer but often the various components of the combination are produced by different companies which creates complexities in terms of pricing and reimbursement…
| Stefanie Tan, Julie Farmer, Monika Roerig, Sara Allin
Internationally and across Canada, governments have explored varied approaches to reforming the governance and financing of primary care with the aim of improving access, efficiency, effectiveness, and patient experiences in the health system. This rapid review prepared for the Institute of Health Economics by the North American Observatory on Health Systems and Policies presents…
| Lucy Mosquera, Khaled El Emam, Lei Ding, Vishal Sharma, Xue Hua Zhang, Samer El Kababji, Chris Carvalho, Brian Hamilton, Dan Palfrey, Linglong Kong, Bei Jiang, Dean Eurich
Getting access to administrative health data for research purposes is a difficult and time-consuming process due to increasingly demanding privacy regulations. An alternative method for sharing administrative health data would be to share synthetic datasets where the records do not correspond to real individuals, but the patterns and relationships seen in the data are reproduced.…
Healthcare systems and organizations, industry, and the public call for support in navigating digital health technologies (DHTs). The authors critically assessed the regulations for DHTs in the U.S., the U.K., and Canada and the DHT-specific health technology assessment (HTA) guidelines, frameworks, and toolkits to describe the current state of practice and propose considerations…
| Charles Yan, Jeff Round, Ilke Akpinar, Chantal Atwood, Lesly Deuchar, Mohit Bhutani, Richard Leigh, Michael Stickland
Appropriate management of chronic obstructive pulmonary disease (COPD) patients following acute exacerbations can reduce the risk of future exacerbations, improve health status, and lower care costs. While a transition care bundle (TCB) was associated with lower readmissions to hospitals than usual care (UC), it remains unclear whether the TCB was associated with cost savings.…
This report identifies extreme heat adaptation strategies that might be feasibly implemented before and during summer 2022, with a focus on vulnerable populations. Information for this report was collected through a rapid review of published and grey literature and summarizes the current evidence on strategy effectiveness and cost, as well as factors influencing implementation…
| Bruce Ritchie, Karen J. B. Martins, Dat Tran, Heather Blain, Lawrence Richer, Scott Klarenbach
Self-administered subcutaneous immunoglobulin G (SCIg) reduces nursing time and eliminates the need for treatment at ambulatory care clinics, as compared with clinic-based intravenously administered IgG (IVIg), and are therapeutically equivalent. Using administrative health data in Alberta, this population-based cohort study examined the costs of IgG administration (SCIg versus…
| Thomas Vilches, Ellen Rafferty, Chad Wells, Alison Galvani, Seyed Moghadas
Diagnostic testing has been pivotal in detecting SARS-CoV-2 infections and reducing transmission through the isolation of positive cases. This study quantified the value of implementing frequent, rapid antigen (RA) testing in the workplace to identify screening programs that are cost-effective. The findings provide important insights which can inform testing strategies. The modeling…
| Sara Allin, Sierra Campbell, Margaret Jamieson, Fiona Miller, Monika Roerig, John Sproule
The Institute of Health Economics contributed as part of the team authoring the Canada Report for the Partnership for Health Sustainability and Resilience (PHSSR) initiative. https://www.phssr.org/findings The report lead author was Dr. Sara Allin, the Director for the North American Observatory on Health Systems and Policies. https://www.dlsph.utoronto.ca/2022/11/15/strengthening-primary-care-key-to-rebuilding-canadas-crumbling-healthcare-system/…
| Charles Yan, Nathan McClure, Sean Dukelow, Balraj Mann, Jeff Round
Increasing demand for provision of care to stroke survivors creates challenges for health care planners. A key concern is the optimal alignment of health care resources between provision of acute care, rehabilitation, and among different segments of rehabilitation, including inpatient rehabilitation, early supported discharge (ESD), and outpatient rehabilitation (OPR). In this…
| Carmen Moga, Mohammad Karkhaneh, Dagmara Chojecki, Bing Guo, Erin Kirwin, Negar Razavilar, Jeff Round, Erica Wright, Charles Yan
Low back pain (LBP) is one of the most common forms of musculoskeletal pain in mid-age adults, with episodic and recurrent pain that can span over the entire life. LBP is a major public health problem worldwide because of its prevalence, associated temporary or permanent disability, and the extensive use of healthcare services by patients. This report aims to identify the appropriate/inappropriate…
| Don Husereau, John Sproule, Ron Vender, Charles Lynde, Jaggi Rao, Jennifer Beecker, Antonella Scali, Christian Boisvert-Huneault, Margaret Peters, Rachael Manion
Pustular psoriasis is a rare form of psoriasis and a chronic disease, with patients experiencing diminished quality of life, reduced productivity, stigma, and shortened life expectancy from disease. Optimal management of pustular psoriasis requires access to healthcare providers with highly specialized knowledge. The rarity of the condition means some patients may receive inappropriate…
This commentary clarifies and reinforces recommendations provided in a recently published article on the second edition of the practical guide for evidence-informed deliberative processes (EDPs): “Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide”. While the practical guide draws on an extensive amount of information…
| Carmel Montgomery, John Sproule, Jeff Round, Christopher McCabe
Using the example of frailty care in Canada, this discussion paper was completed in 2021 and presents an adaptation of the WHO Best Buys principles as a tool to support higher-level decision making and priority setting for high-value healthcare investment. Our goal is to support decision-makers to reduce the preventable and avoidable burden of morbidity, mortality and disability…
| Lindsey Warkentin, Carmen Moga, Lisa Tjosvold, Mohammad Karkhaneh, Bing Guo, Dat Tran, Negar Razavilar, Jeff Round
Since the development of the fiberoptic endoscope in the late 1950s, endoscopy has become an indispensable tool for gastroenterology. The demand for gastrointestinal endoscopy services in Canada has outstripped its availability, resulting in prolonged wait times, patient anxiety and reduced satisfaction, and potential adverse health effects. Capacity for more urgent indications…
| John Sproule, Ken Bond, Lindsey Warkentin, Bing Guo, Nancy Zuck
This report is the result of a national consultation and roundtable deliberations conducted by the Institute of Health Economics to support the development of a National Strategy for Heart Valve Disease in Canada. Two virtual policy engagements with clinical leaders, patients and health system managers were conducted in November 2021. These workshops identified 9 thematic areas…
| Erin Kirwin, Rachel Meacock, Jeff Round, Matt Sutton
The diagonal approach is a health system funding concept wherein vertical approaches targeting specific diseases are combined with horizontal approaches intended to strengthen health systems broadly. This paper aims to develop a theoretical framework for the diagonal approach. It allows concurrent evaluation of three different types of horizontal interventions, those: (i)…
| Samantha Pollard, Dierdre Weymann, Brandon Chan, Morgan Ehman, Sarah Wordsworth, James Buchanan, Timothy P. Hanna, Cheryl Ho, Howard J Lim, Paula Lorgelly, Adam Raymakers, Christopher McCabe, Dean Regier
This study defines a core data set to facilitate economic evaluations of precision oncology. Precision oncology is generating vast amounts of multiomic data to improve human health and accelerate research. Existing clinical study designs and attendant data are unable to provide comparative evidence for economic evaluations. This lack of evidence can cause inconsistent and inappropriate…
| Melanie McPhail, Christopher McCabe, Dean Regier, Tania Bubela
Regulatory and reimbursement decisions for drugs and vaccines are increasingly based on limited safety and efficacy evidence. In this environment, life-cycle approaches to evaluation are needed. A life-cycle approach grants market approval and/or positive reimbursement decisions based on an undertaking to conduct post-market clinical trials that address evidentiary uncertainties,…
| Erin Kirwin, Jeff Round, Ken Bond, Christopher McCabe
This paper presents a Life-Cycle Health Technology Assessment (HTA) framework designed to address three challenges faced by standard HTA: uncertainty, evolving evidence and health system sustainability. The LC-HTA framework is built around on-market evidence generation and risk-based pricing strategies. Where…
Long COVID has no commonly accepted case definition, but is characterized generally as the persistence of any COVID-19 symptoms past the typical convalescence period. Initial reports are emerging of significant ongoing symptom burden for some COVID-19 cases, but the prevalence and profile of these long-term cases, and the potential need for or utilization of community-based supports…
The Institute of Health Economics conducted an environmental scan to: describe available Alberta data assets to support the identification, surveillance, and management of high-risk patients with known cardiovascular disease; identify preliminary gaps in the available information; and formulate potential strategies to address the gaps identified. This environmental scan represents…
Previous reports have examined predictors for inpatient stroke rehabilitation length of stay (LOS) and home discharge. However, none of them has provided a validation benchmark for predictability of identified risk factors. Accordingly, we examined temporal trends, geographic variations, and predicted inpatient rehabilitation LOS and home discharge for stroke patients in Alberta…
| Bing Guo, Carmen Moga, Charles Yan, Gareth Hopkin, Jeff Round, Jennifer Seida, Lisa Tjosvold, Michelle Pollock
This health evidence review assesses the clinical effectiveness and economic impact of various vascular risk reduction (VRR) initiatives that have been implemented in Alberta, and promising new initiatives, to inform priority-setting decisions regarding risk-reduction initiatives. The assessment also examines the clinical benefit that future projects would need to achieve for them…
| Susan Armijo-Olivo, Bing Guo, Nathan McClure, Carmen Moga, Negar Razavilar, Jeff Round, Lisa Tjosvold, Dat Tran, Charles Yan
This health evidence review assesses strategies for the delivery of high-quality and cost-effective stroke rehabilitation care in Alberta to inform decisions about how the province might increase care capacity for stroke rehabilitation services and maximize the benefits of effective treatment interventions. The review assesses two novel approaches to the delivery of high-quality…
| Ellen Rafferty, Laura Reifferscheid, Lawrence Svenson, Margaret Russell, Shannon Macdonald, Stephanie Booth
The impact of universal varicella vaccination on herpes zoster (HZ) risk in unvaccinated and vaccinated children, and its long-term influence on HZ epidemiology, remains unknown. This retrospective cohort study used population-based administrative health data for children born between 1993 and 2018. A universal varicella vaccination programme implementation corresponded to decreased…
| Erin Kirwin, Ellen Rafferty, Kate Harback, Jeff Round, Christopher McCabe
The objective of this study was to implement a model-based approach to identify the optimal allocation of a coronavirus disease 2019 (COVID-19) vaccine in the province of Alberta Canada. The results have three important policy implications: (i) optimal vaccine allocation will depend on the public health policies in place at the time of allocation and the impact of those policies…
The COVID Strategic Choices Group is an interdisciplinary taskforce with experience across different domains of expertise (including epidemiology, public health, public policy, economics and business) and regions of Canada. IHE CEO, Dr. Christopher McCabe is a member of the COVID Strategic Choices Group. Members serve in their individual capacity and not as representatives of any…
This special supplement of Clinical Laboratory News showcases the winning teams from the UNIVANTS Healthcare Excellence Awards. It features innovative programs in Laboratory Medicine. The Institute of Health Economics is pleased to be one of the partners and judges in this prestigious program. Approximately 180 applications were initiated and three top-performing teams were selected…
| Don Husereau, Jennifer Seida, Eddy Nason, John Sproule, Christopher McCabe
The purpose of this report is to provide a summary of current information and stakeholder perspectives regarding the current and future state of regenerative medicine (with a focus on stem cell-based research) in Canada and globally. Specifically, it assesses the strengths, potential areas for improvement, and opportunities for growth in the Canadian sector to ensure the future…
Little is currently known about the overall health service utilization and cost burden in patients with high risk for cardiovascular disease (HRCVD) who are recommended to start a statin to control dyslipidemia to prevent CVD events and mortality in short- and long-term care. We assessed the resource use and healthcare cost burden in this HRCVD patient population in Alberta, Canada,…
The Institute for Health Economics (IHE) conducted a roundtable on PF-ILD, in November 2021 and policy recommendations from the diverse stakeholder group provided some guidance on areas to focus on to improve the lives of those living with progressive fibrosing interstitial lung disease. Key actions identified at the roundtable included: increased surveillance for early identification…
| Christopher Cotton, Christopher McCabe, Esllyt Jones, Evelyn Forget, Fabien Large, Lindsay Tedds, Nathalie de Marcellis-Warren, Richard Gold, Robin Boadway, Stewart Elgie, Stuart Peacock, Vic Adamowicz
The Royal Society of Canada Task Force on COVID-19 was established early in 2020 to equip Canadians with accurate information about Canadian response and recovery. A number of Working Groups were established included one on COVID-19 and Economic Recovery which is chaired by the Institute of Health Economics’ CEO, Dr. Chris McCabe. Their report, "Renewing the Social Contract:…
| Lindsey Warkentin, Erica Wright, Bing Guo, Ken Bond
This Rapid Review assesses the evidence on the rate of COVID-19 transmission from children to children or adults compared with the rate of transmission from adults to others, and the rate of COVID-19 infection in children compared with the rate in adults, to support return-to-school decision making. Twenty-two articles were included in the review. Based on a rapid assessment of…
| Lindsey Warkentin, Erica Wright, Bing Guo, Ken Bond
Face mask use within schools has been suggested as a COVID-19 risk mitigation strategy, but the effectiveness of mask use as protection against COVID-19 transmission and infection in a school setting is currently unknown. This Rapid Review assesses the evidence on the impact of community mask use on the susceptibility to and transmission of COVID-19, and how mask use compliance…
The Institute of Health Economics is proud to be a founding partner of the international Univants of Healthcare Excellence Program https://www.univantshce.com/int/en/program along with 7 other health care organizations. The following article from the September 2020 Journal of Applied Laboratory Medicine outlines twelve diverse best practices which were recognized by the program…
| Sean M. Bagshaw, Dat Tran, Dawn Opgenorth, Xiaoming Wang, Danny Zuege, Armann Ingolfsson, Henry T. Stelfox, Thanh Nguyen
Delay in transfer from intensive care unit (ICU) may contribute to strained capacity. Using a population-based patient cohort in 17 ICUs in Alberta between 2012 and 2016, this paper describes the epidemiologic features and healthcare costs attributable to potentially avoidable delays in ICU discharge. Potentially avoidable discharge delay occurred in approximately 70% of ICU patients…
Summary: Deliberative processes are a well-established part of health technology assessment (HTA) programs in a number of high- and middle-income countries, and serve to combine complex sets of evidence, perspectives, and values to support open, transparent, and accountable decision making. Nevertheless, there is little documentation and research to inform the development…
Primary care services after hours in Alberta are limited, and, as a result, emergency departments have long wait times and overcrowding as they accommodate a greater number of low-acuity conditions. In recent decades, various urgent care models have been established to fill the gap between emergency and primary care, with the aim of providing unscheduled services for urgent but…
This study examined the temporal trends of healthcare service and medicine utilization and explored the care quality of patients with chronic low back pain (CLBP) by assessing inappropriate use of medicine, using Alberta's administrative health data from 1 April 2011 to 31 March 2018. The prevalence of CLBP in Alberta increased from 1.8% FY 2011/12 to 3.0% in FY 2017/18, and the…
There have been few epidemiological studies of dysphagia and associated outcomes using administrative datasets. In this study we estimate the proportion of patients with either stroke or head and neck cancer who are additionally diagnosed with dysphagia or aspiration pneumonia, or that have a feeding tube placed. Our analysis is based on a cohort of patients identified in administrative…
Summary: We examined the association between optimal control of dyslipidemia and mortality and healthcare costs in patients with high risk for cardiovascular disease (HRCVD) between 2012-2016 in Alberta, Canada. HRCVD patients who were optimally controlled had lower mortality and incurred modestly higher costs, compared to those who were not. Secondary prevention patients with…
| Dat Tran, Ilke Akpinar, Irvin Mayers, Tatiana Makhinova, Philip Jacobs
The objective of this study, published in the International Journal of Chronic Obstructive Pulmonary Disease, was to describe the trends in pharmacologic treatment for patients newly diagnosed with chronic obstructive pulmonary disease (COPD) in Alberta, Canada.
PDF of a PowerPoint presentation by Dr. Carl May, Professor of Medical Sociology at the London School of Hygiene and Tropical Medicine.
Implementation Science Breakfast Plenary
| Charles Yan, Katherine Rittenbach, Sepideh Souri, Peter H. Silverstone
This analysis, published in BMC Psychiatry, aimed to determine cost-effectiveness of a stepped-care pathway for depression in adults in primary care versus standard care (SC), treatment-as-usual (TAU), and online cognitive behavioural therapy (CBT).
| Samuel N. Frempong, Andrew J. Sutton, Clare Davenport, Pelham Barton
The aim of this study, published in PharmacoEconomics – Open, was to conduct an early economic analysis of a hypothetical rapid test for typhoid fever diagnosis in Ghana and identify the necessary characteristics of the test for it to be cost effective in Ghana.
This study, published in PharmacoEconomics – Open, reports exploratory analysis of the provincial and nationwide costs of industry-sponsored drug clinical trials (CTs) in Canada. The costs of industry-sponsored drug CTs completed in 2016 were Can$2.1 billion. In addition to the creation of knowledge, these trials play an important role in alleviating the healthcare cost burden…
| Dat Tran, Thanh Nguyen, Arto Ohinmaa, Irvin Mayers, Philip Jacobs
OBJECTIVES: To examine the resource use and healthcare costs for chronic obstructive pulmonary disease (COPD) in Alberta, Canada between 2008 and 2016 and model the future costs to 2030.
Clinical research is funded by industry, governments, charities, and hospitals. It is important to know the economic commitment of the various funding bodies, but until now there has been no national source available which provides these data. We surveyed the major funders to provide such a measure. There is evidence that government and charity funding of medical research is a…
| Helena M Earl, Louise Hiller, Anne-Laure Vallier, Shrushma Loi, Karen McAdam, Luke Hughes-Davies, Adrian N Harnett, Mei-Lin Ah-See, Richard Simcock, Daniel Rea, Sanjay Raj, Pamela Woodings, Mark Harries, Donna Howe, Kerry Raynes, Helen B Higgins, Maggie Wilcox, Chris Plummer, Janine Mansi, Ioannis Gounaris, Betania Mahler–Araujo, Elena Provenzano, Anita Chhabra, Jean E Abraham, Carlos Caldas, Peter S Hall, Christopher McCabe, Claire Hulme, David Miles, Andrew M Wardley, David A Cameron
Adjuvant trastuzumab significantly improves outcomes for patients with HER2-positive early breast cancer. The standard treatment duration is 12 months but shorter treatment could provide similar efficacy while reducing toxicities and cost. We aimed to investigate whether 6-month adjuvant trastuzumab treatment is non-inferior to the standard 12-month treatment regarding disease-free…
| Michelle Pollock, Ann Scott, Jennifer Seida, Paula Corabian, Andrew J. Sutton, Mike Paulden, Christopher McCabe, Lisa Tjosvold, Bing Guo
The clinical review and economic evaluation aimed to determine how Oncotype DX and Prosigna can be optimally used to determine which patients with early-stage breast cancer will benefit from adjuvant chemotherapy. This report addresses the following research question: For patients with early-stage (I–III), ER+, HER2?, node-negative or node-positive (one to three nodes) breast…
PDF of a PowerPoint presentation by Prof Braunack-Mayer, Head, School of Health and Society, University of Wollongong, Australia.
Big Questions about Big Data Event
| Timothy Caulfield, Alessandro R Marcon, Blake Murdoch, Jasmine Brown, Sarah Tinker Perrault, Jonathan Jarry, Jeremy Snyder, Samantha J Anthony, Stephanie Brooks, Zubin Master, Christen Rachul, Ubaka Ogbogu, Joshua Greenberg, Amy Zarzeczny, Robyn Hyde-Lay
Abstract: Numerous social, economic and academic pressures can have a negative impact on representations of biomedical research. We review several of the forces playing an increasingly pernicious role in how health and science information is interpreted, shared and used, drawing discussions towards the role of narrative. In turn, we explore how aspects of narrative are used in…
| Dat Tran, Thanh Nguyen, Dawn Opgenorth, Xiaoming Wang, Danny Zuege, David A. Zygun, Henry T. Stelfox, Sean M. Bagshaw
This study, published in the Journal of Critical Care, explores the association between strained ICU capacity and healthcare costs, and demonstrates the admissions to ICUs experiencing strain incur incremental costs, attributed to longer hospitalization and physician services.
| Paula Corabian, Bing Guo, Carmen Moga, Ann Scott
This article retrospectively examines the evolution of rapid assessments (RAs) produced by the Health Technology Assessment (HTA) Program at the Institute of Health Economics over its 25-year relationship with a single requester, the Alberta Health Ministry (AHM).
| Paula Corabian, Bing Guo, Carmen Moga, Ann Scott
The Health Technology Assessment Program at the Institute of Health Economics has conducted rapid assessments (RAs) since 1993. This information paper draws on this experience and describes the evolution of RA process and products over a 25-year relationship with a single requester to quantify the effects of this partnership on the RAs produced. The aim is to contribute to emergent…
| Nancy Zuck, John Sproule, Charles Cook, Rebecca Albrecht
Alberta Health initiated the Nurse Practitioner Demonstration Project(s) (NPDP) in 2016 to support access to and further integration of Nurse Practitioners (NPs) into Alberta’s primary health care system. Funding was provided (based on diverse program plans) to the Boyle McCauley Health Centre (BMHC), The Alex Community Health Centre (The Alex), the Calgary Urban Project…
Ce rapport fournit un résumé d’un atelier de sprint sur la conception de données probantes du monde réel (DPMR) qui a eu lieu le 21 octobre 2018 à Toronto, en Ontario. L’atelier a été conçu et offert dans le cadre d’un partenariat entre l’Agence canadienne des médicaments et des technologies…
On November 23rd in Calgary and November 30th in Edmonton, the Institute of Health Economics (IHE) hosted an educational workshop designed to support both early and late stage organizations in developing an understanding of when, where, and how health economics can be used to strengthen product and business planning, and satisfy requirements of purchasers of technology. Participants…
PDF of a PowerPoint presentation by Dan Palfrey, Director, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Dr. Christopher McCabe, Executive Director and CEO of the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Dr. Christopher McCabe, Executive Director and CEO of the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Dan Palfrey, Director, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Andrew Sutton, Senior Health Economist, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Andrew Sutton, Senior Health Economist, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
This report provides a summary of a real-world evidence (RWE) design sprint workshop that took place on October 21, 2018 in Toronto, Ontario. The workshop was developed and delivered as a joint partnership between the Canadian Agency for Drugs and Technologies in Health (CADTH); Canadian Association for Population Therapeutics (CAPT), Health Canada, and the Institute of Health…
| Dat Tran, Robert Welsh, Arto Ohinmaa, Thanh Nguyen, Padma Kaul
Little is known about the resource use and cost burden of acute myocardial infarction (AMI) beyond the index event. We examined resource use and care costs during the first and each subsequent year, among patients with incident AMI.
This environmental scan describes existing initiatives that aim to accelerate the diagnostic phase of cancer care in Alberta, Canada, and internationally. Specifically, it describes their development and implementation, structure and functioning, intended outcomes and effectiveness, costs and cost savings, and enablers and barriers.
PDF of a PowerPoint presentation by Dr. Kelvin Chan MD FRCPC MSc (Clin Epi) MSc (Biostats) PhD, Sunnybrook Odette Cancer Centre.
IHE/CAPT Real World Evidence Workshop
PDF of a PowerPoint presentation by Dr. Tammy Clifford, Chief Scientist and Vice-President, Evidence Standards, and Dr. Trevor Richter, Director, Common Drug Review and Optimal Use at CADTH.
IHE/CAPT Real World Evidence Workshop
On October 21, 2018, Health Canada, the Canadian Agency for Drugs and Technologies in Health (CADTH), the Institute of Health Economics (IHE), and the Canadian Association for Population Therapeutics (CAPT) collaborated on Defining Decision-Grade Real-World Evidence and its Role in the Canadian Context: A Design Sprint. Held as a satellite to the 2018 CAPT conference in Toronto,…
In the development of early stage life sciences technology, it's imperative to understand whether healthcare organizations are likely to purchase your innovation, and consequently provide a return on investment. Healthcare organizations make purchase decisions based upon clinical AND economic (value for money) considerations. Our early stage technology assessment service can help…
Realistic Medicine is the 18th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
The Institute of Health Economics (IHE) is a unique collaborative arrangement among government, academia, and industry. Established in 1995, the IHE is committed to gathering and disseminating evidence-based findings from health economics, health policy, health technology assessment and comparative effectiveness research to support health policy and practice.
| S.P. Bisch, T. Wells, L. Gramlich, P. Faris, X. Wang, Dat Tran, Thanh Nguyen, S. Glaze, P. Chu, P. Ghatage, J. Nation, V. Capstick, H. Steed, J. Sabourin, G. Nelson
The Institute of Health Economics has contributed to a study published in the Journal Gynecologic Oncology. The study described the effects of Enhanced Recovery After Surgery (ERAS) guideline implementation in gynecologic oncology on length of stay, patient outcomes, and economic impact in Alberta. The study compared pre-and post-guideline implementation outcomes at two centers…
This study originated from discussions on how to translate research findings into conclusions regarding safety and effectiveness in systematic reviews responding to requests from a provincial mechanism for introducing and diffusing publicly funded healthcare technologies. Its objective is to identify prominent and reliable evidence grading systems used in health technology assessment…
This clinical practice guideline was produced as part of the Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project, which was initiated to establish criteria for IG therapy as a means to increase accountability for the quality, safety, and sustainability of the blood supply system, and to demonstrate stewardship for the use of public funds. This project…
This background document outlines the methods used to develop the Criteria for the Clinical Use of Immune Globulin, which was produced as part of the Prairie Collaborative Immune Globulin Utilization Management Framework project. The Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project was initiated to establish criteria for IG therapy as a means…
PDF of a PowerPoint Presentation by George Habib, President and CEO, Lung Association of Ontario.
Facilitating Adoption of Innovation Practices (COPD) Panel – HTAi Annual Meeting 2018
PDF of a PowerPoint presentation by Shelley Valaire, Senior Provincial Director, Respiratory Health Strategic Clinical Network (RHSCN), Alberta.
Facilitating Adoption of Innovation Practices (COPD) Panel – HTAi Annual Meeting 2018
PDF of PowerPoint presentation by Tatiana Makhinova, Assistant Professor, Faculty of Pharmacy and Pharmaceutical Services, University of Alberta.
Facilitating Adoption of Innovation Practices (COPD) Panel – HTAi Annual Meeting 2018
| Jasmine Brown, Roger Bland, Egon Jonsson, Andrew Greenshaw
Objective: Fetal alcohol spectrum disorder (FASD) is a medical term used to describe a range of mental and physical disabilities caused by maternal alcohol consumption. The role of alcohol as a teratogen and its effects on the cellular growth of the embryo and the fetus were not determined on scientific grounds until the late 1960s. However, the link between alcohol use during…
| Jasmine Brown, Roger Bland, Egon Jonsson, Andrew Greenshaw
Objective: Fetal Alcohol Spectrum Disorder (FASD) is a preventable disorder caused by maternal alcohol consumption and marked by a range of physical and mental disabilities. Although recognized by the scientific and medical community as a clinical disorder, no internationally standardized diagnostic tool yet exists for FASD. Methods and Results: This review seeks to analyse the…
| Charles Yan, Yufei Zheng, Michael D. Hill, Balraj Mann, Thomas Jeerakathil, Noreen Kamal, Shy Amlani, Anderson Chuck
Abstract: We present a conceptual approach to determine the optimal solution to delivering a health technology, consistent with the objective of maximizing patient outcomes subject to resources available to a publicly funded health system. The article addresses two key policy questions: 1) adding system values through appropriate planning of health services delivery and 2) considering…
This brief outlines some perspectives from the Institute of Health Economics (IHE) based on what we have heard from government, public agencies, and industry, and seeks to summarize the key areas where further clarification and deliberation could be helpful.
As the Federal Government contemplates introducing an element of value-based pricing to the pharmaceutical industry regulatory framework, this report provides an overview of key theoretical and empirical material, to support informed engagement by all stakeholders in this important debate.
PDF of a PowerPoint presentation by Dr. Brian O’Rourke, CEO, Canadian Agency for Drugs and Technology in Health.
Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making Forum
PDF of a PowerPoint presentation by Dr. Sean Tunis, President, Health Technology Assessment International; Founder and CEO, Centre for Medical Technology Policy.
Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making Forum
| Rodger Craig, Carmen Moga, Bing Guo, Dagmara Chojecki
The Institute of Health Economics (IHE) was commissioned by the Canadian Cardiovascular Society to provide a rapid update of the literature, to compare the impacts of public reporting and external benchmarking on selected outcomes, and to evaluate and describe the applicability of this body of research to non- competitive health systems, emphasizing perspectives and considerations…
Objective: The aim of this study was to analyze the health care costs and savings associated with quality improvement (QI) interventions initiated and implemented utilizing the National Surgical Quality Improvement Program (NSQIP). Background: Five acute care facilities of Alberta Health Services (AHS) adopted NSQIP in 2015 for a pilot project. Methods: The cost-savings of NSQIP…
This report provides a summary of the proceedings from the IHE roundtable on diabetes care and management in Indigenous populations in Canada, held on November 1, 2017. The roundtable aimed to: discuss and share learnings and promising practices from successful community-led diabetes programs, highlighting approaches to effectively engage communities to co-develop prevention and…
Since 2000, 5 studies have been published that each purported to estimate aggregate national mental health costs in Canada. Each of these studies used a different method. Our aim was to compare the studies, and we created a framework for the different elements used to assess mental health costs (direct costs, indirect costs, transfer payments, and “human” costs). In…
This report provides a summary of the IHE/CAPT Precision Health workshop that took place on October 22, 2017 in Toronto, Ontario. The intent of the workshop was to identify gaps and opportunities in implementing precision health technologies into the Canadian health system. The workshop was supported by unrestricted grants from Merck Canada and Hoffmann-La Roche Limited.The views…
Presenteeism (reduced productivity at work) is thought to be responsible for large economic costs. Nevertheless, much of the research supporting this is based on self-report questionnaires that have not been adequately evaluated.
| Dat Tran, Ilke Akpinar, Richard Fedorak, Egon Jonsson, John Mackey, Lawrence Richer, Philip Jacobs
Purpose: In pharmaceutical clinical trials, industrial sponsors pay for study drugs and related healthcare services. We conducted a study to determine industry’s economic contribution of these trials to the Alberta healthcare system. Authors and Affiliations: Dat T. Tran1,2; Ilke Akpinar2 ; Richard N. Fedorak3 ; Egon Jonsson2 ; John R. Mackey4 ; Lawrence Richer5 ; Philip…
On November 1st, 2017, the Institute of Health Economics (IHE) hosted a pan-Canadian roundtable discussion regarding diabetes care and management in indigenous populations in Canada. This event was sponsored through an educational grant from Boehringer Ingelheim Canada, and was developed in consultation with an advisory committee including: Mr. Mehmood Alibhai (Boehringer Ingelheim…
On November 1st, 2017, the Institute of Health Economics (IHE) hosted a pan-Canadian roundtable discussion regarding diabetes care and management in indigenous populations in Canada. This event was sponsored through an educational grant from Boehringer Ingelheim Canada, and was developed in consultation with an advisory committee including: Mr. Mehmood Alibhai (Boehringer Ingelheim…
PDF of a PowerPoint presentation by John Sproule, Senior Policy Director, Institute of Health Economics.
Diabetes Care and Management in Indigenous Populations in Canada: A Pan-Canadian Roundtable
PDF of a PowerPoint presentation by Addie Pryce, Director of Health, Assembly of First Nations.
Diabetes Care and Management in Indigenous Populations in Canada: A Pan-Canadian Roundtable
PDF of a PowerPoint presentation by Hesham Nabih, President, HN Consultants Ltd.
Diabetes Care and Management in Indigenous Populations in Canada: A Pan-Canadian Roundtable
PDF of a PowerPoint presentation by Amelia Tekwatonti McGregor, Elder and Community Advisory Board Member, Kahnawake Schools Diabetes Prevention Project.
Diabetes Care and Management in Indigenous Populations in Canada: A Pan-Canadian Roundtable
PDF of a PowerPoint presentation by Dr. Dean Eurich, Professor, School of Public Health, University of Alberta, and Kari Meneen, Team Lead, RADAR; Diabetes Care Coordinator, OKAKI Health Intelligence Inc.
Diabetes Care and Management in Indigenous Populations in Canada: A Pan-Canadian Roundtable
PDF of a PowerPoint presentation by Ms. Jenney Samuelson, Vermont Blueprint for Health Expansion and Quality Improvement Program (EQuIP).
Health Policy Dialogues
On October 22, 2017, in conjunction with the 2017 Annual CAPT Conference, the Institute of Health Economics (IHE) and the Canadian Association for Population Therapeutics (CAPT) co-hosted the IHE/CAPT Precision Health Workshop. Precision Health (PH) has potential to provide a wide range of solutions such as enhanced R&D efficiency, earlier diagnosis and time to treatment,…
PDF of a PowerPoint presentation by Jennifer Pillay, MSc Student, University of Alberta.
IHE/CAPT Precision Health (PH) Workshop – Integrating Precision Health into the Canadian Health System.
PDF of a PowerPoint presentation by Katherine Bonter, Director of Intellectual Property, Clementia Pharmaceuticals Inc.
IHE/CAPT Precision Health (PH) Workshop – Integrating Precision Health into the Canadian Health System.
PDF of a PowerPoint presentation by Kelly Robinson, Director, Health Products and Food Branch, Health Canada.
IHE/CAPT Precision Health (PH) Workshop – Integrating Precision Health into the Canadian Health System.
| Bing Guo, Paula Corabian, Charles Yan, Lisa Tjosvold
This evidence-based report examines expanding the role of paramedics in the community. It summarizes the various types of community paramedicine programs (characteristics, implementation, and funding sources in other jurisdictions) as well as the safety, effectiveness, and economic outcomes of these paramedic programs towards providing patients with alternate, non-emergency health…
PDF of a PowerPoint presentation by Dr. Des Gorman, Professor of Medicine and Associate Dean, Faculty of Medical and Health Sciences, University of Auckland; Executive Chairman of Health Workforce New Zealand.
Health Policy Dialogues
This lists all the documents/websites relevant to the guideline that are available on the IHE and TOP websites, both clinician and patient resources.
Link to Alberta Ambassador Guideline Adaptation Program
L’IHE dans votre poche 2017 – Guide de statistiques sur l’économie de la santé présente et divise les données les plus récentes en sections portant sur le fardeau économique de la maladie, les ressources en soins de santé, les comportements liés à la santé, l'état de santé, les…
This paper reviews implementation of enhanced recovery after surgery (ERAS) and its financial implications. Literature on clinical outcomes and financial implications were reviewed. Reports from many different surgery types shows that implementation of ERAS reduces complications and shortens hospital stay. These improvements have major impacts on reducing the cost of care even…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This STE report examines the social and system demographics, technological safety and therapeutic efficacy/effectiveness, cost-effectiveness, and budget impact of endovascular therapy for acute ischemic stroke, contextualized to the Alberta setting. Section Authors: Section…
This background document outlines the methods used to develop the Alberta Clinical Practice Guideline (CPG) for Management of Primary Headache in Adults, which was produced as part of the Alberta Ambassador Guideline Adaptation Program.
Link to Alberta Ambassador Guideline Adaptation Program
This lists all the documents/websites relevant to the guideline that are available on the IHE and TOP websites, both clinician and patient resources.
Link to Alberta Ambassador Guideline Adaptation Program
This report provides a summary of the IHE Real-World Evidence Roundtable, which took place on December 12, 2016. The intent of the roundtable was to capture initial thinking regarding preferences and perceptions of the use of real-world evidence for pricing and reimbursement of new medicines in Canada and what more may be needed.
This report provides a summary of the IHE Biosimilars Forum engagement exercise that took place on April 23, 2017 in Ottawa, Ontario. The intent of the forum was to identify: options to categorize and consider biosimilars; a process to engage stakeholders to identify place in therapy and further evidence development that may be required; and an approach to knowledge exchange that…
IHE In Your Pocket 2017 – A Handbook of Health Economic Statistics includes the most currently available data, presented in separate sections on the economic burden of illness, health care resources, health behaviours, health status and demographics, and health system performance. IHE In Your Pocket was designed to provide a compact, comprehensive, and comparative overview…
| Thanh Nguyen, Ilke Akpinar, Jennifer Gratrix, Sabrina Plitt, Petra Smyczek, Ron Read, Philip Jacobs, Tom Wong, Ameeta E Singh
Adding universal rectal screening to urogenital screening should positively impact rectal Chlamydia trachomatis (CT) incidence in affected populations. A dynamic Markov model was used to evaluate costs and outcomes of three rectal CT screening strategies among women attending sexually transmitted infection clinics in Alberta, Canada: universal urogenital-only screening (UG-only),…
Building a Community-Based Health System: Lessons for a Path Forward is the 17th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PDF of a PowerPoint presentation by Dr. Muhamad Elrashidi, Kern Center Population Health Scholar, Mayo Clinic.
IHE Innovation Forum XVII – Building a Community-Based Health System: Lessons for a Path Forward
PDF of a PowerPoint presentation by Mr. Nigel Edwards, CEO, Nuffield Trust.
IHE Innovation Forum XVII – Building a Community-Based Health System: Lessons for a Path Forward
This IHE Biosimilars Invitational Forum provided the perspective of international, national, and Alberta speakers and panellists who described the biosimilar reimbursement approach taken and outcomes achieved by other jurisdictions, guiding principles and policy options for Alberta, and key performance indicators and targets for reimbursement policy going forward. Towards a Framework…
Alberta Health Services (AHS) has established a number of Strategic Clinical Networks (SCNs) in the province around specific health care topics (e.g., Cardiovascular Health & Stroke) and within areas where care is delivered (e.g., Surgery). The SCNs are the engines of innovation in the health system and have a mandate to find new and innovative ways of delivering care to provide…
This background document outlines the methods used to update the Alberta Clinical Practice Guideline (CPG) for the Evidence-Informed Primary Care Management of Low Back Pain, which was produced as part of the second phase of the Alberta Health Technology Assessment (HTA) Ambassador Program.
Link to Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Ms. Kim Wieringa, Assistant Deputy Minister, Health Information Systems, Alberta Health.
e-Health Policy Symposium – Towards “Person-Centred” Integrated Health in Alberta
PDF of a PowerPoint presentation by Dr. Doreen Rabi, Clinical Endocrinologist, Associate Professor, University of Calgary.
e-Health Policy Symposium – Towards “Person-Centred” Integrated Health in Alberta
PDF of a PowerPoint presentation by Ms. Kathleen Ness, Assistant Deputy Minister, Health Service Delivery Division, Alberta Health.
e-Health Policy Symposium – Towards “Person-Centred” Integrated Health in Alberta
PDF of a PowerPoint presentation by Dr. Robert Reid, Chief Scientist, Trillium Health Partners, Institute for Better Health, Mississauga, Ontario.
e-Health Policy Symposium – Towards “Person-Centred” Integrated Health in Alberta
This symposium addressed the importance of integrated health information as a necessary foundation for improved patient and system outcomes. The focus of the symposium was to discuss the benefits and challenges of shared health information and to better understand the role that health care providers play individually and collectively in achieving more person-centred and integrated…
PDF of a PowerPoint presentation by Ms. Annamarie Fuchs, IMAGINE Citizens, Collaborating for Health.
e-Health Policy Symposium – Towards “Person-Centred” Integrated Health in Alberta
PDF of a PowerPoint presentation by Dr. Jennifer Zelmer, President, Azimuth Health Group; Editor-in-Chief, Healthcare Policy, Toronto, Ontario.
e-Health Policy Symposium – Towards “Person-Centred” Integrated Health in Alberta
The Institute of Health Economics (IHE) Life Sciences Open Innovation Platform™ is an online “ideasourcing” platform to encourage a broad pan-Canadian community to comment on key issues and topics related to life science policy. Preliminary campaigns will focus on biosimilars policy. Ideas with the most support will be used to inform policy discourse at an IHE…
This report provides a summary of recently published information (January 2015 to present) regarding the glucose monitoring technologies that are commercially available in North America, as well as those that are emerging within the next five years (up to 2021).
The Value in Health Invitational Forum provided an overview from provincial, national, and international leaders around key issues to consider and address from a system perspective when developing an approach to extract value from a complex health system. The concept of system organization for a) development of standards, b) accountability arrangements and roles, and c) approaches…
PDF of a PowerPoint presentation by Dr. Francois Belanger, Vice President, Quality and Chief Medical Officer for Alberta Health Services, and Dr. Blair O'Neill, Associate Chief Medical Officer, Strategic Clinical Networks, Alberta Health Services.
Value in Health Forum: Standards, Quality, and Economics
PDF of a PowerPoint presentation by Dr. Reinhard Busse, Department of Health Care Management, Berlin University of Technology; Co-founder, European Observatory on Health Systems.
Value in Health Forum: Standards, Quality, and Economics
PDF of a PowerPoint presentation by Dr. Murray Ross, Vice President and Lead, Kaiser Health Policy Institute, Kaiser Permanente.
Value in Health Forum: Standards, Quality, and Economics
PDF of a PowerPoint presentation by Dr. Robert Nesse, Senior Medical Advisor, Healthcare Policy and Payment Reform for Mayo Clinic.
Value in Health Forum: Standards, Quality, and Economics
PDF of a PowerPoint presentation by Dr. Meredith Rosenthal, Professor of Economics and Associate Dean, School of Public Health, Harvard University.
Value in Health Forum: Standards, Quality, and Economics
PDF of a PowerPoint presentation by Dr. Richard Glazier, Senior Core Scientest and Chair of the Primary Care and Population Health Program at ICES.
Value in Health Forum: Standards, Quality, and Economics
| Alain Lesage, Roger Bland, Ian Musgrave, Egon Jonsson, Mike Kirby, Helen-Maria Vasiliadis
The Liberal government committed to making mental health services more accessible. Housing funding was increased in the last budget, but now commitment to comprehensive home care for the severely mentally ill and access to primary care treatments for common mental disorders are needed.
| John Paul Ekwaru, Arto Ohinmaa, Sarah Loehr, Solmaz Setayeshgar, Thanh Nguyen, Paul J Veugelers
Objective: Public health decision makers not only consider health benefits but also economic implications when articulating and issuing lifestyle recommendations. Whereas various estimates exist for the economic burden of physical inactivity, excess body weight and smoking, estimates of the economic burden associated with our diet are rare. In the present study, we estimated the…
On December 12th, 2016, the Institute of Health Economics (IHE) held a roundtable discussion regarding the role of real-world evidence (RWE) in decision-making in Canada, with a focus on RWE generated for pricing and reimbursement. The meeting brought together 11 representatives of key stakeholders: experts in evidence assessment, payers, and those generating RWE including academia…
This overview report provides a summary of the published information on the oxygen therapy issues studied in the past 10 years in the acute care settings. The report includes a summary of audit studies that aimed to address appropriate/inappropriate use of oxygen, and explores the safety and quality issues identified in the literature about oxygen prescription, administration,…
This report provides a summary of the IHE Biosimilars Forum engagement exercise that took place on October 6, 2016 in Edmonton. The intent of the forum was to inform Alberta biosimilar reimbursement policy by sharing international experiences in this area, and the perspectives of key stakeholders.
This rapid report provides a summary of current evidence on the application of gainsharing shared savings strategies in healthcare systems and the barriers and facilitators related to their implementation.
Economic evaluation helps policy makers and healthcare payers make decisions on drug listing, coverage, and reimbursement. When economic evaluations are conducted before a product launch, the prices of the pharmaceuticals have to be forecast.
PDF of a PowerPoint presentation by Dr. Gregory P. Marchildon, Ontario Research Chair in Health Policy and System Design and Professor, Institute of Health, Policy and Evaluation, University of Toronto; Associate Editor of the Health Reform Observer and originating member of the Pan-Canadian Health Reform Analysis Network (PHRAN). IHE Innovation Forum XVI – Controlling Health…
Controlling Health Care Costs – Wisely is the 16th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
The Institute of Health Economics (IHE), in partnership with the Canadian Pulmonary Fibrosis Foundation (CPFF), held a forum on April 25th, 2016 in Toronto, Ontario, entitled Optimizing access to care for patients with idiopathic pulmonary fibrosis: A multi-stakeholder national forum, to discuss the need for patient-led policy recommendations and a patient charter for idiopathic…
| Thanh Nguyen, Anderson Chuck, Tracy Wasylak, Jeannette Lawrence, Peter Faris, Olle Ljungqvist, Gregg Nelson, Leah Gramlich
BACKGROUND: In February 2013, Alberta Health Services established an Enhanced Recovery After Surgery (ERAS) implementation program for adopting the ERAS Society colorectal guidelines into 6 sites (initial phase) that perform more than 75% of all colorectal surgeries in the province. We conducted an economic evaluation of this initiative to not only determine its cost-effectiveness,…
This IHE Invitational Forum provided the perspective of international, national, and Alberta speakers and panellists who described the biosimilar reimbursement approach taken and outcomes achieved by other jurisdictions, guiding principles and policy options for Alberta, and key performance indicators and targets for reimbursement policy going forward.
PDF of a PowerPoint presentation by Mr. Murray Aitken, Senior VP and Executive Director, IMS Institute for Healthcare Informatics.
6 Oct 2016 – IHE Biosimilars Forum
This white paper follows on from the 2016 IHE report, Economic surveillance for chronic obstructive pulmonary disease (COPD) in Alberta. It provides a summary of main gaps in COPD care across Canada and, in the context of a broad economic framework, it surveys important examples of programs and policies designed to address these gaps.
| Arto Ohinmaa, Yufei Zheng, Thomas Jeerakathil, Scott Klarenbach, Unto Häkkinen, Thanh Nguyen, Dan Friesen, Jane Ruseski, Padma Kaul, Ruolz Ariste, Philip Jacobs
OBJECTIVES: This study aimed to evaluate the trends and regional variation of stroke hospital care in 30-day in-hospital mortality, hospital length of stay (LOS), and 1-year total hospitalization cost after implementation of the Alberta Provincial Stroke Strategy.
“The Canadian Idiopathic Pulmonary Fibrosis Patient Charter is a way to call upon policymakers, health care providers and private payers to recognize IPF as a rare, rapidly lethal, chronic disease and to join in the campaign for greater awareness of this illness. The ultimate goal is to improve the overall quality and standards of care and ensure equal access to a continuum…
High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients? is the 15th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PDF of a PowerPoint presentation by Mr. Truman Severson, Vice President, Innovation and Business Development, Covenant Health.
IHE Innovation Forum XV – High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients?
PDF of a PowerPoint presentation by Dr. Clemens Hong, MD, MPH, Medical Director, Community Health Improvement, Community Health & Integrated Programs, County of Los Angeles Department of Health Services.
IHE Innovation Forum XV – High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients?
PDF of a PowerPoint presentation by Dr. Richard Lewanczuk, Senior Medical Director, Provincial Primary Health Care, Alberta Health Services; Professor, Department of Medicine, University of Alberta.
IHE Innovation Forum XV – High Needs & High Cost Patients in Healthcare – How do we improve outcomes for these patients?
| Thanh Nguyen, Justin Ezekowitz, Dat Tran, Padma Kaul
BACKGROUND: Eplerenone has been demonstrated as being cost effective for the treatment of patients with systolic heart failure (HF) and mild symptoms in several jurisdictions; however, its cost effectiveness is unknown in the context of Alberta, Canada.
Objective: The objective of this paper is to estimate the additional mental health service costs incurred within the criminal justice system that are incurred because of people with mental illnesses who go through the system. Our focus is on costs in Alberta.
The Institute of Health Economics (IHE) together with the O’Brien Institute for Public Health (O’Brien Institute) held a policy forum on February 8th, 2016, entitled Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration to inform decision-making regarding the fiscal sustainability of theprovincial healthcare system, with a specific…
| Anderson Chuck, Thanh Nguyen, James Wesenberg, Rhada Chari, Robert Wilson, Selikke Janes-Kelley
Objectives: In 2006, the Alberta Ministry of Health issued a policy to implement fetal fibronectin (fFN) testing as a publicly funded service for pregnant women. The goals were to reduce maternity health care utilization and unnecessary treatment, which would result in cost-savings for the health system by more accurately diagnosing false preterm labour. We conducted a post-policy…
This guide has been developed by the information specialists at the Institute of Health Economics in Edmonton Alberta and is intended to facilitate searching for health technology assessments (HTAs) or systematic reviews by providing the list of current and reliable internet-based resources that we regularly use in our work. We have tried as much as possible to match this guide…
PDF of a PowerPoint presentation by Dr. Martin Kolb, MD, PhD, Professor, Division of Respirology, Department of Medicine, McMaster University.
Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis: A Multi-stakeholder National Forum
PDF of a PowerPoint presentation by Dr. Meena Kalluri, MD, Assistant Professor, Division of Pulmonary Medicine, University of Alberta.
Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis: A Multi-stakeholder National Forum
PDF of a PowerPoint presentation by Mr. Robert Davidson, President, Canadian Pulmonary Fibrosis Foundation (CPFF).
Optimizing Access to Care for Patients with Idiopathic Pulmonary Fibrosis: A Multi-stakeholder National Forum
In October 2015, we held the first Canadian consensus discussion that led to provisional recommendations regarding special considerations for policy-making and healthcare decisionmaking for interventions in patients with idiopathic pulmonary fibrosis (IPF). The meeting included 11 representatives of key stakeholders: patients, care providers, and policy researchers from across…
On April 25th, The Institute of Health Economics (IHE), in partnership with the Canadian Foundation for Pulmonary Fibrosis (CPFF) and supported by an unrestricted grant from Boehringer Ingelheim (Canada) Ltd. (BI), held a national, multi-stakeholder roundtable forum to discuss policy recommendations on idiopathic pulmonary fibrosis (IPF) care.
| Arianna Waye, Philip Jacobs, Maria Ospina, Michael Stickland, Irvin Mayers
This report provides the results of an economic surveillance analysis on the components of the Alberta healthcare system that are devoted to COPD prevention and treatment. It focuses on epidemiology (prevalence and incidence), service use, and cost indicators, and identifies gaps in the system that presumably add to the overall economic burden of COPD. PDF of the above image: IHE…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This STE report examines the safety, screening accuracy, therapeutic efficacy/effectiveness, cost-effectiveness, budget impact, and health system readiness of newborn screening for seven conditions (galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle…
Objectives: To estimate the life expectancy and specify the causes of death among people with fetal alcohol syndrome (FAS). Methods: Included were all patients recorded in Alberta provincial databases of inpatients, outpatients, or practitioner claims from 2003 to 2012. People with FAS were identified by ICD-9 code 760.71 and ICD-10 codes Q86.0 and P04.3, and were linked…
The IHE quality appraisal checklist for case series studies developed by a group of researchers at the Institute of Health Economics (IHE) in collaboration with researchers from two other health technology assessment (HTA) agencies in Australia and Spain.
The IHE Quality Appraisal Checklist for Case Series Studies and guidance document developed by a group of researchers at the Institute of Health Economics (IHE) in collaboration with researchers from two other health technology assessment (HTA) agencies in Australia and Spain.
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This rapid report has been produced in response to a request from Alberta Health to provide an update on the new published research evidence on the efficacy/effectiveness, efficiency, and safety of hysteroscopic tubal sterilization (HTS) using the Essure® system for permanent…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of the “Technological efficacy/effectiveness analysis” (T) section of the 2014 Alberta STE report, which was an evidence assessment of the clinical effectiveness and safety of endovenous ablation interventions for symptomatic varicose veins…
Abstract: Canada having a universal health insurance plan that provides hospital and physician benefits offers a natural experiment of whether continuity ofcare actually provides lower or higher utilization of services. The question we are evaluating is whether Canadians, who have a regular physician, use more health resources than those who do not have one? Using two statistical…
The Institute of Health Economics (IHE) together with the O’Brien Institute for Public Health (O’Brien Institute) held a policy forum on February 8th, 2016, entitled Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration to inform decision-making regarding the fiscal sustainability of the provincial healthcare system, with a specific focus…
The IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities and Remuneration Policy Forum aims to inform decision-making regarding the fiscal sustainability of the provincial healthcare system, with a specific focus on physicians as stewards of public resources. The forum, which will also be attended by Health Minister Sarah Hoffman as lunch keynote speaker,…
PDF of a PowerPoint presentation by Dr. William Ghali, MD, MPH, FRCPC, Scientific Director, O'Brien Institute for Public Health.
IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum
PDF of a PowerPoint presentation by Dr. David Naylor, President Emeritus and Professor of Medicine, University of Toronto.
IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum
PDF of a PowerPoint presentation by Dr. Peter Kaboli, Hospitalist and Chief of Medicine, Iowa City VA Healthcare System.
IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum
PDF of a PowerPoint presentation by Dr. David Price, Professor and Chair, Department of Family Medicine, McMaster University.
IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum
PDF of a PowerPoint presentation by Dr. Sharon Straus, Professor, Department of Medicine, University of Toronto.
IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum
PDF of a PowerPoint presentation by Dr. Carl Nohr, President, Alberta Medical Association, and Mr. Mike Gormley, Executive Director, Alberta Medical Association.
IHE/O’Brien Physicians as Stewards of Resources: Roles, Responsibilities, and Remuneration Policy Forum
| Angus Thompson, Maria Ospina, Liz Dennett, Arianna Waye, Philip Jacobs
Presenteeism, reduced productivity while working, has come into consideration as a major occupational health problem in many countries with serious consequences for both organizations and employees. Increasing evidence shows that presenteeism represents a significant source of productivity losses that can cost organizations much more than does absenteeism, and it can lead to an…
This report is from an Alberta Strategic Clinical Networks (SCN) exchange meeting with Mr. Neil Fraser. This event brought together SCNs and related health system stakeholders, and a leader in the Canadian medical technology industry, and recent member of a Federal Advisory Panel on Healthcare Innovation. The meeting had the objectives to help the SCNs to understand the Advisory…
Background: Significant gaps in the evidence base on costs in rural communities in Canada and elsewhere are reported in the literature, particularly regarding costs to families. However, it remains unclear whether the costs related to all resources used by palliative care patients in rural areas differ to those resources used in urban areas.
Strengthening Mental Health Services for Children and Families is the 14th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PDF of a PowerPoint presentation by Dr. Stan Kutcher, ONS, MD, FRCPC, FCAHS, Sun Life Financial Chair in Adolescent Mental Health, Dalhousie University and IWK Health Centre.
IHE Innovation Forum XIV – Strengthening Mental Health Services for Children and Families
The Institute of Health Economics held a roundtable on June 4, 2015, entitled Innovative Funding Models: Kidney Care Policy Options for the Future, to identify and discuss key issues in kidney care policy options. Prior to the roundtable, an Innovative Funding Models: Kidney Care Policy Options for the Future Steering Committee teleconference refined project objectives, and the…
The purpose of this workshop was to examine COPD management in Canada through presentation of analyses and examples of system supports to action best practices to a select group of clinical leaders and relevant public sector decision makers. The group deliberated, and key themes and policy recommendations from discusssion were captured to form the basis of the final COPD Policy…
PDF of a PowerPoint presentation by Dr. Irvin Mayers, Professor, Division of Pulmonary Medicine, University of Alberta; Chair of the COPD Policy Framework Study Expert Advisory Committee.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Dr. Arianna Waye, Health Economist, Institute of Health Economics.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Mr. Michael G. Stewart, Director, Clinical Support Branch, Ontario Ministry of Health and Long-Term Care.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Dr. Michael Stickland, Associate Professor, Division of Pulmonary Medicine, University of Alberta; Heart & Stroke Foundation New Investigator.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Dr. Simon Lessard, Quebec Lung Association Board & Scientific Committee Member, Community Pharmacist.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Dr. Cathy Clelland, Head of Department of Family Practice, Royal Columbian Hospital; Consultant, General Practitioners Services Committee, British Columbia.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
PDF of a PowerPoint presentation by Mr. Stephen Samis, Vice President, Programs, Canadian Foundation for Healthcare Improvement; and Dr. Graeme Rocker, Professor of Medicine, Dalhousie University; Faculty, Canadian Foundation for Healthcare Improvement.
Chronic Obstructive Pulmonary Disease (COPD) Care Canada Policy Workshop
The Institute of Health Economics (IHE), in partnership with Boehringer Ingelheim (Canada) Ltd./Ltée held an invitational forum on October 3, 2015, in Edmonton, Alberta. The purpose of this discussion was to bring together multiple stakeholders from across Canada to investigate the current state of evidence and information regarding idiopathic pulmonary fibrosis (IPF) and…
Objective: In this study, we estimate the impact of the new PCV13 immunization program on the burden of disease and related healthcare costs in Alberta.
OBJECTIVES: To examine differences in health services utilization (HSU) costs in the first year of life between low birth weight (LBW) and normal birth weight (NBW) infants, identify maternal and child characteristics associated with HSU costs, and estimate annual HSU cost of LBW infants for the province of Alberta, Canada.
| Bing Guo, Carmen Moga, Christa Harstall, Don Schopflocher
Objective: Because of a lack of a control group, a case-series study is considered one of the weaker study designs from which to obtain evidence on treatment effectiveness. Under certain circumstances, however, this is the only available evidence to inform health-care decisions. This study's intent was to develop and validate a quality appraisal checklist specifically for…
| Werner J Becker, Ted Findlay, Carmen Moga, Ann Scott, Christa Harstall, Paul Taenzer
Objective: To increase the use of evidence-informed approaches to diagnosis, investigation, and treatment of headache for patients in primary care.
Note: This is an Alberta Ambassador Guideline Adaptation Program related publication.
Alberta Health Services (AHS) has recently established a number of Strategic Clinical Networks (SCNs) in the province around specific health care topics (e.g., Cardiovascular Health & Stroke) and within areas where care is delivered (e.g., Surgery). The SCNs are the engines of innovation in the health system and have a mandate to find new and innovative ways of delivering care…
| Don Husereau, Larry Arshoff, Shahira Bhimani, Nicola Allen
This document describes the entry of new medical devices into the Canadian health system. It is intended to provide an accurate description of new medical device entry in Canada, and is intended to give patients, the public, private and public sector health system researchers, medical device companies, and private and public coverage bodies a general understanding of what regulatory,…
Written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report provides an assessment of how the adoption of fFN testing in Alberta impacted the clinical management of preterm labour and healty system resources. This was also an opportunity to retroactively use the Post Policy Implementation Framework to evaluate a specific policy developed within…
PDF of a PowerPoint presentation by Mr. Neil Fraser, President & GM, Medtronic Canada, Incoming Chair of MEDEC.
SCN/MEDEC Workshop: Partnering for Health System Innovation in Alberta
PDF of a PowerPoint presentation by Dr. Blair O'Neill, Associate Chief Medical Officer, SCNs.
SCN/MEDEC Workshop: Partnering for Health System Innovation in Alberta
PDF of a PowerPoint presentation by Mr. Jitendra Prasad, Chief Program Officer, Contracting, Procurement & Supply Management, AHS.
SCN/MEDEC Workshop: Partnering for Health System Innovation in Alberta
We reviewed literature to estimate the costs of Fetal Alcohol Spectrum Disorder (FASD) in the Canadian Criminal Justice System (CJS), and to update the total costs of FASD in Canada. The results suggest FASD is costlier than previous estimates. The costs of FASD associated with the CJS are estimated at $3.9 billion a year, with $1.2 billion for police, $0.4 billion for court,…
| Julie Polisena, John Lavis, Don Juzwishin, Pam McLean-Veysey, Ian Graham, Christa Harstall, Janet Martin
A perceived gap exists in how well Canadian health technology assessment (HTA) producers are supporting the use of their HTAs by decision-makers. The authors propose that the newly released HTA Database Canadian search interface incorporate structured decision-relevant summaries of HTAs that would be developed by participating Canadian HTA organizations. The registry would…
| Ann Scott, Dion Pasichnyk, Christa Harstall, Dagmara Chojecki
This Information Paper is an inventory and broad summary of factors affecting the adoption and diffusion of health technologies and of available models, strategies, tools, and processes for optimizing health technology diffusion.
| Braden Manns, Anderson Chuck, Eddy Nason, Lianne Barnieh, John Sproule, Jasmine Brown
This work, conducted by the Institute for Health Economics (IHE) and the University of Calgary (Health Economics group), was performed to better understand the unmet educational needs and health economics products that could support people in the province, and to determine the current capacity for conducting health economics in Alberta. This paper seeks to understand the needs…
Better Information - Better Health: Accessing Health and Health-Related Data in Alberta is the 13th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PDF of a PowerPoint presentation by Dr. Andrew Bjerring, Council of Canadian Academies.
IHE Innovation Forum XIII – Better Information - Better Health: Accessing Health and Health-Related Data in Alberta
PDF of a PowerPoint presentation by Mr. William Falk, Rotman School of Management, University of Toronto.
IHE Innovation Forum XIII – Better Information - Better Health: Accessing Health and Health-Related Data in Alberta
Objectives: Economic evaluations, although not formally used in purchasing decisions for medical devices in Canada, are still being conducted and published. The aim of this study was to examine the way that prices have been included in Canadian economic evaluations of medical devices.
Economic surveillance and economic assessments are important sources of information to help administrators and policy makers to track current trends and evaluate policies and care patterns. The Institute of Health Economics, in partnership with Alberta Health, held a two-day Costing Methods Workshop which helped to review costing practices by bringing together economists and other…
| Deborah Marshall, Egon Jonsson, Liam Martin, Diane Mosher, Karen V. MacDonald
This White Paper discusses the concept of developing a comprehensive rheumatoid arthritis registry in Alberta, and the important health, social, and economic gains such a resource would generate for Alberta.
The Federal Minister of Health, the Honourable Rona Ambrose, announced the creation of the Advisory Panel on Healthcare Innovation (Panel) on June 24, 2014, to examine innovative health care ideas and approaches that exist in Canada and internationally. The Panel’s mandate is to identify promising innovations, here and internationally, which could help Canada reduce growth…
This book includes the plenary presentations made at the first international conference on prevention of FASD, which was attended by about 700 people from 35 countries around the globe. The issues addressed are FASD as a priority in health policy making; its prevalence and incidence; strategies for prevention; current applied and basic research in the field; the role of the medical…
Fetal alcohol spectrum disorder (FASD) is of growing concern around the world. A range of disabilities caused by prenatal exposure to alcohol, FASD is estimated to affect 2% to 5% of all newborns in the industrialized countries of Europe and North America, and the rates may be significantly higher in some developing countries and certain defined populations. Epidemiological studies…
The federal Minister of Health, the Honourable Rona Ambrose, announced the creation of the Advisory Panel on Healthcare Innovation (Panel) on June 24, 2014, to examine innovative health care ideas and approaches that exist in Canada and internationally. The Panel’s mandate is to identify promising innovations, here and internationally, which could help Canada reduce growth…
| Maria Ospina, Liz Dennett, Arianna Waye, Philip Jacobs, Angus Thompson
Objectives: To assess and compare the measurement properties (ie, validity, reliability, responsiveness) and the quality of the evidence of presenteeism instruments.
| Thanh Nguyen, Egon Jonsson, Jessica Moffatt, Liz Dennett, Anderson Chuck, Shelley Birchard
Abstract: Parent-Child Assistance Program (P-CAP) is a 3-year home visitation/harm reduction intervention to prevent alcohol exposed births, thereby births with fetal alcohol spectrum disorder, among high-risk women. This article used a decision analytic modelling technique to estimate the incremental cost-effectiveness ratio and the net monetary benefit of the P-CAP…
PDF of a PowerPoint Presentation by Dr. Siok Swan Tan, Erasmus University, institute for Medical Technology Assessment (iMTA).
On the State of the Art in Costing Methods Workshop.
PDF of a PowerPoint Presentation by Mrs. Lesley Curtis, Personal Social Services Research Unit (PSSRU), UK.
On the State of the Art in Costing Methods Workshop.
PDF of a PowerPoint Presentation by Dr. Unto Häkkinen, National Institute for Health and Welfare (THL).
On the State of the Art in Costing Methods Workshop.
Economic surveillance and economic assessments are important sources of information to help administrators and policy makers to track current trends and evaluate policies and care patterns. The Institute of Health Economics, in partnership with Alberta Health, held a two-day Costing Methods Workshop which helped to review costing practices by bringing together economists and other…
PDF of a PowerPoint Presentation by Ms. Karen Lee, Canadian Agency for Drugs and Technologies in Health (CADTH).
On the State of the Art in Costing Methods Workshop.
PDF of a PowerPoint Presentation by Mr. Michael Stewart, Ontario Ministry of Health and Long-Term Care (MOHLTC).
On the State of the Art in Costing Methods Workshop.
PDF of a PowerPoint Presentation by Mr. Anyk Glussich, Program Lead, Canadian Patient Cost Database (CPCD); Canadian Institute for Health Information (CIHI).
On the State of the Art in Costing Methods Workshop.
| Lindsay Wodinski, Kate Woodman, Margaret Wanke, Thanh Nguyen, Philip Jacobs
Abstract: Alberta's Primary Care Networks (PCNs) bring together family physicians and other health professionals to provide local, comprehensive, and readily accessible primary care services to patients. The Edmonton North PCN, one of the largest in the province, piloted the Resource in Clinic (RIC) Program with objectives to increase efficiencies in the use of physician…
Primary Care Low Back Exam factsheet - 2006.
Extracted from the Chronic Pain Management Binder November 2005.
Link to Alberta Ambassador Guideline Adaptation Program
À titre de président du jury, le Dr Alain Lesage, M.D., FRCPC, M.Phil., DFAPA, professeur au département de psychiatrie de l'Université de Montréal et clinicien à l’Institut universitaire en santé mentale de Montréal, Québec, a dirigé un comité spécial dont le mandat était d'élaborer…
This consensus development conference was commissioned by the Government of Alberta to improve the transition of its system of care for people with severe and persistent mental illness (SPMI) toward the community. The system, previously hospital- and institution-centred, is moving towards becoming a community-centred, patient- and family-led one. The development and deployment…
| Caroline Sheppard, Erica Lester, Anderson Chuck, David Kim, Shahzeer Karmali, Christopher Gara, Daniel Birch
INTRODUCTION: The objective of this study was to determine the short-term cost impact thatmedical tourism for bariatric surgery has on a public healthcare system. Due to long wait times for bariatric surgery services, Canadians are venturing to private clinics in other provinces/countries. Postoperative care in this population not only burdens the provincial health system…
In November 2014, the Institute of Health Economics partnered with Eli Lilly Canada Inc. and the Canadian Institutes of Health Research’s Institute for Health Services and Policy Research to hold a roundtable to discuss the federal role in healthcare innovation. The roundtable aimed to examine the existing state of healthcare innovation, its strengths and weaknesses (or gaps),…
Health System Standards: From Good Intent to Real World Application is the 12th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PDF of a PowerPoint Presentation by Dr. Ken Butcher, WMC Health Sciences Centre, University of Alberta. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference In this 45 minute presentation, Dr. Butcher reviewed how to diagnose stroke and discussed the burden of Cardioembolic and Cryptogenic Stroke. He talked about the recent…
PDF of a PowerPoint Presentation by Dr. Thomas Jeerakathil, Associate Professor, University of Alberta; Co-physician lead, ASPIRE TIA Triaging Project, Northern Stroke Lead CV/S SCN. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference This presentation looked at the diagnosis of likely TIA syndromes and how to identify and…
PDF of a PowerPoint Presentation by Dr. Blair O’Neill, Professor of Medicine, University of Alberta; Interventional Cardiologist, Mazankowski AHI; Senior Medical Director, CV Health and Stroke SCN, Alberta Health Services; Past President, Canadian Cardiovascular Society. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference…
This free forum for primary care clinicians was held in conjunction with the annual Accelerating Primary Care conference in Edmonton, Alberta, November 23, 2014. The forum saw three physician leaders review the latest developments in the continuously advancing field of stroke prevention and care, with a particular focus on the role of primary care. The forum was…
PDF of a PowerPoint Presentation by Dr. Blair O’Neill, Professor of Medicine, University of Alberta; Interventional Cardiologist, Mazankowski AHI; Senior Medical Director, CV Health and Stroke SCN, Alberta Health Services; Past President, Canadian Cardiovascular Society. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference…
Objectives: To estimate the annual health services utilization (HSU) cost per person with FASD by sex and age; the lifetime HSU cost per person with FASD by sex, and the annual HSU cost of FASD for Alberta by sex.
The purpose of this roundtable was to gather a small, select group of thought leaders to engage in informed discourse, which was summarized in a report submitted to the new federal Healthcare Innovation Advisory Panel. This roundtable, created in response to the Federal Healthcare Innovation Advisory Panel’s call for stakeholder input, was an exciting opportunity to…
| Victoria Ung, Thanh Nguyen, Karen Wong, Karen Kroeker, Thomas Lee, Haili Wang, Arto Ohinmaa, Philip Jacobs, Richard Fedorak
BACKGROUND & AIMS: Infliximab is effective for induction and maintenance of response in patients with moderate to moderately severe ulcerative colitis. Previous cost analyses of infliximab treatment for ulcerative colitis used models of colectomy vs infliximab and response rates derived from early clinical trials. In real life, therapeutic options are more complex; patients…
The Institute of Health Economics, in collaboration with the Government of Alberta and with support from Alberta Health Services (AHS) hosted the Consensus Development Conference on Improving Mental Health Transitions in Edmonton, Alberta, from November 4 - 6, 2014.
PDF of a PowerPoint presentation by Dr. Philippa Garety, MA, MPhil, MA (Ed), PhD, FBPsS.
Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Roger Bland, CM, MB, ChB, FRCPC, FRCPsych.
Consensus Development Conference on Improving Mental Health Transitions
Real World Evidence: Priority Setting for Action was an invitational roundtable discussion organized by the Institute of Health Economics (IHE) and supported by and developed in partnership with Strategy for Patient Oriented Research Support Unit (Ontario) and AstraZeneca Canada. It was held in conjunction with the annual Canadian Association for Population Therapeutics (CAPT).…
Real World Evidence: System Readiness – Are we ready to use routinely collected data to improve health system performance? Summary Report Real World Evidence: Priority Setting for Action was an invitational roundtable discussion organized by the Institute of Health Economics (IHE) and supported by and developed in partnership with Strategy for Patient Oriented Research Support…
PDF of a PowerPoint presentation by Dr. Muhammad Mamdani, Director, Applied Health Research Centre, St. Michael's Hospital.
Real World Evidence: Priority Setting for Action Roundtable
PDF of a PowerPoint presentation by Mr. Neil Corner, Director, Innovative Solutions (Real World Evidence Lead) at IMS Brogan.
Real World Evidence: Priority Setting for Action Roundtable
| Don Husereau, Anthony Culyer, Peter Neumann, Philip Jacobs
Abstract: Canadian and US health systems have often been characterized as having vastly different approaches to the financing and delivery of healthcare, with Canada portrayed as more reliant on rationing based on costs. In this article, we examine the similarities and differences between the two countries, the evolution and current role of health economic evaluation, and…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the clinical effectiveness and safety of hysteroscopic tubal sterilization, and the value for money associated with adopting hysteroscopic tubal sterilization in Alberta. Section Authors: Section One – Background and Context: Carmen…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the best available research evidence on the safety and effectiveness, cost effectiveness and budget impact of using Endovenous Laser Ablation (EVLA) or Endovenous Radiofrequency Ablation (RFA) in the management of symptomatic varicose…
| Arto Ohinmaa, Thanh Nguyen, Cheryl Barnabe, Liam Martin, Anthony Russell, Susan G Barr, Walter Maksymowych
OBJECTIVE: To provide Canadian estimates of health care utilization costs associated withrheumatoid arthritis (RA)-related and non-RA-related care within 4 treatment strategies and in different physical functioning categories.
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the safety, screening accuracy, therapeutic efficacy, patient outcomes and cost effectiveness of first trimester Quad (1T-Quad) +/- NT and NIPT screening for fetal trisomies. Section Authors: Section One – Technology Effectiveness and Safety: Ken Bond,…
| Cheryl Barnabe, Thanh Nguyen, Arto Ohinmaa, Joanne Homik, Susan G Barr, Liam Martin, Walter Maksymowych
OBJECTIVE: Sustained remission in rheumatoid arthritis (RA) results in healthcare utilizationcost savings. We evaluated the variation in estimates of savings when different definitions ofremission [2011 American College of Rheumatology/European League Against Rheumatism Boolean Definition, Simplified Disease Activity Index (SDAI) ≤ 3.3, Clinical Disease Activity Index…
| Carolyn Dewa, Desmond Loong, Sarah Bonato, Thanh Nguyen, Philip Jacobs
BACKGROUND: Interest in the well-being of physicians has increased because of their contributions to the healthcare system quality. There is growing recognition that physicians are exposed to workplace factors that increase the risk of work stress. Long-term exposure to high work stress can result in burnout. Reports from around the world suggest that about one-third to…
Summary of Systematic Reviews, Primary Studies, and Evidence-based Guidelines. The following research questions were addressed in this review: What are the clinical effects of a universal screening strategy for ARO carriage when compared with no screening? What are the clinical effects of a universal screening strategy for ARO carriage when compared with targeted screening (screening…
| Don Husereau, Philip Jacobs, Braden Manns, Ties Hoomans, Deborah Marshall, Robyn Tamblyn
This discussion paper has been produced in response to a request from CIHR Institute of Health Services and Policy Research (CIHR IHSPR). The discussion paper will provide guidance to those tasked with conducting an economic evaluation of complex health system interventions. The guidance will be an elaboration of existing National guidelines for economic evaluation, and serve as…
Antibiotic-Resistant Organisms (AROs) are a serious health problem, though they are more prevalent in some settings than others. We were asked to make findings and develop recommendations on how to address surveillance of and screening for AROs in acute care hospitals. This consensus statement addresses these requests. However, confining the discussion and recommendations to hospitals…
PDF of a PowerPoint presentation by Dr. Elizabeth Bryce, BSc, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Daniel Gregson, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Lindsay Nicolle, BSc, BSc (med), MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Anthony Harris, MD, MPH.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Barry Cookson, BDS, MBBS, MSc, HonDipHIC, FRSPH, FRCP, FFPH, FRCPath.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Ms. Kim Neudorf.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Yves Longtin, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Trish Perl, MD, MSc.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Eli Perencevich, MD, MS.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Mark Loeb, BSc, MSc, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Serge Desnoyers, PhD.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Pilar Ramon-Pardo, MD, PhD.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Howard Njoo, MD, MHSc.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Julian Davies, BSc, PhD, FRS.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Scott McEwen, DVM, DVSc, Dip ACVP.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Joel Kettner, MD, MSc, FRCSC, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Andrew Simor, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Robert Weinstein, MD.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. James Talbot, PhD, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. David Patrick, MD, FRCPC, MHSc.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Michael Edmond, MD, MPH, MPA.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Henri Verbrugh, MD, PhD, FIDSA.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Allison McGeer, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Susan Huang, MD, MPH.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. John Jernigan, MD, MS.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
The 3-day Canadian Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) held in Calgary, Alberta from June 18 - 20, 2014, was the first event of its kind to look at issues in the field of AROs.
| Carolyn Dewa, Philip Jacobs, Thanh Nguyen, Desmond Loong
BACKGROUND: Interest in the impact of burnout on physicians has been growing because of the possible burden this may have on health care systems. The objective of this study is toestimate the cost of burnout on early retirement and reduction in clinical hours of practicingphysicians in Canada.
The objective of this paper is to estimate the additional costs to the criminal justice system associated with people with mental illness who go through the system. The focus of the report is on costs in Alberta.
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the potential role of low dose computed tomography (LDCT) in screening for lung cancer in adults aged 50 years or older in Alberta. Section Authors: Section One – Social and System Demographics Analysis: Bing Guo, Dagmara Chojecki Section Two –…
PDF of PowerPoint Presentation by Dr. Dianne Mosher, Chief, Division of Rheumatology, Department of Medicine, University of Calgary.
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Dr. Liam Martin, Professor, University of Calgary.
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Ms. Cheryl Koehn, Founder and President, Arthritis Consumer Experts (ACE).
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Dr. Micheal Guirguis, Drug Stewardship Pharmacist, Alberta Health Services (AHS).
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Ms. Suzanne Lepage, Private Health Plan Strategist.
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Dr. Agnes Klein, Director, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics at Health Canada, Health Canada. Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium Note: Slide 16 of this presentation contains an error…
PDF of a PowerPoint Presentation by Dr. Chander Sehgal, Director, Common Drug Review (CDR) and Optimal Use, Canadian Agency for Drugs and Technologies in Health (CADTH).
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PDF of a PowerPoint presentation by Dr. Sube Banerjee, Brighton and Sussex Medical School.
IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
PDF of a PowerPoint presentation by Dr. Duncan Robertson, Seniors Health Strategic Clinical Network, Alberta Health Services.
IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
PDF of a PowerPoint presentation by Dr. Carole Estabrooks, University of Alberta.
IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
PDF of a PowerPoint presentation by Dr. David C. Grabowski, Harvard Medical School.
IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
This informative PowerPoint is publicly available for use as an introductory resource for justice professionals who are seeking an educational tool to assist in group presentations/training regarding involvement of those with Fetal Alcohol Spectrum Disorder (FASD) in the criminal justice system.
Le PowerPoint informative est publiquement disponible pour une utilisation en tant que ressource d'introduction pour les professionnels de la justice qui cherchent un outil pédagogique pour aider à des présentations de groupe / formation concernant la participation de ceux qui ont des troubles causés par l'alcoolisation fœtale (ETCAF ) dans le…
Should vitamin B12 tablets be included in more Canadian drug formularies? An economic model of the cost-saving potential from increased utilisation of oral versus intramuscular vitamin B12 maintenance therapy for Alberta seniors. OBJECTIVE: The aim of this study was to estimate the cost-savings attainable if all patients aged ≥65 years in Alberta, Canada, currently on…
OBJECTIVES: The objective of this study was to explore the degree to which databases otherthan MEDLINE contribute studies relevant for inclusion in rapid health technology assessments (HTA).
This report has been produced in response to a request from Alberta Health (AH). The objective was to perform a review of practices of engaging committees composed of lay people or members of the general public at international, national, provincial, and regional levels. The review attempts to address the following questions: What scientific evidence is available about committees…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
| Lianne Barnieh, Braden Manns, Anthony Harris, Marja Blom, Cam Donaldson, Scott Klarenbach, Don Husereau, Diane Lorenzetti, Fiona Clement
BACKGROUND: The use of a restrictive formulary, with placement determined through a drug-reimbursement decision-making process, is one approach to managing drug expenditures.
IHE In Your Pocket 2014 – a handbook of health economic statistics includes the most currently available data, presented in separate sections on the economic burden of illness, health care resources, health behaviours, health status and demographics, and health system performance. IHE In Your Pocket was designed to provide a compact, comprehensive, and comparative overview…
Abstract: The cost of drug development is commonly cited between US$800 and US$1.8 billion. A similar statistic for vaccines is yet to be estimated, and it is unclear whether the cost of vaccines is similar to drug development. Financial and regulatory policy significantly impacts the extent and cost of pharmaceutical development, and as such it is important that…
| Thanh Nguyen, Anderson Chuck, Arto Ohinmaa, Philip Jacobs
Objectives: To estimate the monetary benefits of ramipril and its distribution over time among four beneficiaries in Canada: the drug developing manufacturer, generic manufacturers, the healthcare sector and employment sectors.
PDF of a PowerPoint presentation by Dr. Louis Hugo Francescutti, President, Canadian Medical Association.
Disclaimer: please be aware that some of these images may be considered very disturbing or graphic to some viewers.
IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective
PDF of a PowerPoint presentation by Dr. Sam Shortt, Canadian Medical Association.
IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective
PDF of a PowerPoint presentation by Dr. Richard Lewanczuk, Alberta Health Services.
IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective
PDF of a PowerPoint presentation by Dr. Tom Feasby, University of Calgary.
IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective
PDF of a PowerPoint presentation by Dr. Bill Hnydyk, Alberta Medical Association.
IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective
PDF of a PowerPoint presentation by Ms. Cathy Pryce, Alberta Health Services.
IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective
Choosing Wisely® in Health Care: A Canadian Perspective is the tenth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally. Choosing Wisely® is an initiative of the ABIM Foundation to improve health care in the United…
| Christa Harstall, Paul Taenzer, Nancy Zuck, Donna Angus, Carmen Moga, Ann Scott
Rationale, Aims, and Objectives: The Alberta Ambassador Program (AAP) adapted seven clinical practice guidelines on low back pain (LBP) into a single guideline spanning the continuum of care from prevention and diagnosis through to treatment. The Ambassador adaptation process was evaluated to 1 Identify the major challenges encountered and successful strategies utilized;…
INTRODUCTION: Varicella vaccine was introduced to the infant immunization schedule in each province or territory between 2000 and 2007 as a result of the Canadian ImmunizationStrategy. The impact of vaccinating children against this disease is potentially far reaching, asimmunization may also benefit those segments of the population not immunized. The objective of this paper…
This report is an analysis of the theoretical basis for value-based pricing, relevant international developments, and areas for improvement within Canada’s current patented drug pricing system. This report intends to inform future policy research, advice, and Canadian drug policy discussions regarding the feasibility and implementation of value-based pricing approaches.
PDF of a PowerPoint presentation by Mr. Deepa Singal, Mrs. Teresa Brown, and Mr. Albert Chudley.
First International Conference on the Prevention of FASD
PDF of a PowerPoint presentation by Dr. Malcolm King, SFU Faculty of Health Sciences; CIHR Institute of Aboriginal Peoples’ Health.
First International Conference on the Prevention of FASD
PDF of a PowerPoint presentation by Dr. Akinori Hisashige, Institute of Healthcare Technology Assessment, Japan.
First International Conference on the Prevention of FASD
PDF of a PowerPoint presentation by Dr. Joanne Weinberg, Professor and Distinguished University Scholar, University of British Columbia.
First International Conference on the Prevention of FASD
This consensus statement on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD) is the product of a unique IHE Consensus Development Conference held in September 2013. The event was a three-day juried hearing of evidence and scientific findings that allowed for the engagement and collaboration of citizens and decision makers in government and the justice system in addressing…
IHE hosted the First International Conference on Prevention of FASD, September 23 - 25, 2013 in Edmonton, Alberta. More than 800 people were in attendance, including global experts and leaders in the health system, government, and the academic and business communities. Well-known speakers from around the world presented facts and findings from research, and described innovative…
PDF of a PowerPoint presentation by Mr. Jonathan Rudin, Program Director, Aboriginal Legal Services of Toronto; Chair, FASD Justice Committee.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by The Honourable Judge Sheila Whelan, Provincial Court of Saskatchewan.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Ms. Donna Debolt, Social Work Consultant, Edmonton, Alberta.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Gail Andrew, Board Member, Canada FASD Research Network; Medical Site Lead, Pediatrics; Medical Director, FASD Clinical Services; Pediatric Consultant, Glenrose Rehabilitation Hospital.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Stephen Greenspan, Emeritus Professor of Educational Psychology, University of Connecticut; Clinical Professor of Psychiatry, University of Colorado.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Arlin Pachet, Clinical Neuropsychologist, Adjunct Assistant Professor, Department of Psychology, University of Calgary.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
Alcohol can hurt the brain and body of an unborn baby and cause Fetal Alcohol Spectrum Disorder (FASD), a serious lifelong condition that impacts both the individual and their family. A child with FASD becomes an adult with FASD, facing birth defects, developmental and learning delays and social, educational, and employment challenges.
PDF of a PowerPoint presentation by Dr. Sterling Clarren, CEO and Scientific Director, Canada Northwest FASD Research Network; Clinical Professor of Pediatrics; Faculty of Medicine, University of British Columbia; Clinical Professor of Pediatrics, School of Medicine, University of Washington. Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum…
PDF of a PowerPoint presentation by Dr. Kathy Sulik, Professor of Cell Biology and Physiology; Member of the Bowles Center for Alcohol Studies, University of North Carolina, Chapel Hill, NC, USA.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Philip Jacobs, Professor of Health Economics, Faculty of Medicine, University of Alberta; Director of Research Collaborations, IHE.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Ms. Fia Jampolsky, Chair, Yukon Human Rights Commission; Lawyer, Cabott and Cabott, Whitehorse.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Larry Burd, Professor, Department of Pediatrics, University of North Dakota School of Medicine; Director of the North Dakota Fetal Alcohol Syndrome Center and PAS Clinic.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Ab Chudley, Professor, Department of Pediatrics, University of Manitoba; Medical Director, Winnipeg Regional Health Authority Program in Genetics and Metabolism.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Jacqueline Pei, Assistant Professor, Department of Educational Psychology; Assistant Clinical Professor, Department of Pediatrics, University of Alberta.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Mr. William Edwards, Deputy Public Defender, Los Angeles County Public Defender's Office.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Allan Manson, Professor, Faculty of Law, Queen's University, Kingston, Ontario.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Ms. Patricia MacPherson, Senior Research Manager, Correctional Service of Canada.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
| Angus Thompson, Philip Jacobs, Jessica Moffatt, Arianna Waye
This service and evaluation project originated from the Alberta courts via the collaboration of two Alberta Ministries; (1) Alberta Justice & Soliciter General and (2) Alberta Environment and Sustainable Resource Development. The impetus arose when a judge in an environmental protection case observed a need for additional attention to the mental health of workers. An Alberta…
This background document outlines the methods used to develop the Alberta Clinical Practice Guideline (CPG) for Management of Primary Headache in Adults, which was produced as part of the Alberta Ambassador Guideline Adaptation Program.
Link to Alberta Ambassador Guideline Adaptation Program
| Thanh Nguyen, Jessica Moffatt, Philip Jacobs, Anderson Chuck, Egon Jonsson
Objectives: To estimate the break-even effectiveness of the Alberta Fetal Alcohol Spectrum Disorder (FASD) Service Networks in reducing occurrences of secondary disabilities associated with FASD.
Early Childhood Development: Advancing Children’s Health is the ninth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally.
Early Childhood Development: Advancing Children’s Health is the ninth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally.
Abstract: Medical wait time is a top health policy issue in Canada. Reliable data on the referral wait time from primary to specialty care are limited. Existing data on referral wait times are generally self-reported by specialists. In 2008, the Edmonton North Primary Care Network (PCN) developed a Centralized Referral Program, including a specialist database that contains…
The Provincial Industry Payer Agreements in an Era of National Purchasing Strategies half-day invitational roundtable was part of the IHE's ongoing Methodology Forum series supported by the Institute of Health Economics, the Alberta government, and industry partners, AstraZeneca, Merck, and Eli Lilly. The event brought together academic experts, industry leaders and senior decision…
The Provincial Industry Payer Agreements in an Era of National Purchasing Strategies half-day invitational roundtable was part of the IHE's ongoing Methodology Forum series supported by the Institute of Health Economics, the Alberta government, and industry partners, AstraZeneca, Merck, and Eli Lilly. The event brought together academic experts, industry leaders and senior decision…
The Provincial Industry Payer Agreements in an Era of National Purchasing Strategies half-day invitational roundtable was part of the IHE's ongoing Methodology Forum series supported by the Institute of Health Economics, the Alberta government, and industry partners, AstraZeneca, Merck, and Eli Lilly. The event brought together academic experts, industry leaders and senior decision…
PDF of a PowerPoint presentation by Mr. Eddy Nason, Senior Researcher, Institute of Governance.
Provincial Industry Payer Agreements in an Era of National Purchasing Strategies Roundtable.
PDF of a PowerPoint presentation by Dr. Michael Drummond, Professor of Health Economics, University of York, UK.
Provincial Industry Payer Agreements in an Era of National Purchasing Strategies Roundtable.
PDF of a PowerPoint presentation by Diane McArthur, Assistant Deputy Minister, Ontario Ministry of Health and Long Term Care.
Provincial Industry Payer Agreements in an Era of National Purchasing Strategies Roundtable.
This health technology assessment report has been produced in response to a request from Alberta Health (AH) as part of the Alberta Health Technologies Decision Process (AHTDP) to perform an evaluation of the scientific evidence on the safety and effectiveness of TMJ Concepts® and Biomet® Microfixation TMJ prostheses for adults who are indicated for total TMJ replacement.…
Transcutaneous Bilirubinometry for the Screening of Hyperbilirubinemia in Neonates ≥35 Weeks’ Gestation This report was prepared for Alberta Health Services (AHS) and focuses on the published evidence about the safety, test accuracy, and clinical impact of the use of transcutaneous bilirubin (TcB) test for the screening of significant hyperbilirubinemia in term or late…
The review summarizes the current evidence on the safety, efficacy, effectiveness, and potential cost-effectiveness on the use of the BridgePoint Medical System (consisting of the CrossBoss™ catheter, Stingray™ catheter, and Stingray™ guidewire) for the recanalization of refractory coronary chronic total occlusions (CTOs). The report also describes the relevant…
| Thanh Nguyen, Egon Jonsson, Jessica Moffatt, Liz Dennett
From the Introduction: In this paper, we report a discussion of available evidence regarding the association between poverty and FASD, and regarding the economic consequences of FASD on individuals and families which may materialize an FASD - poverty trap.
The Institute of Health Economics, in partnership with Alberta Enterprise and Advanced Education, Alberta Health, and Eli Lilly Canada, conducted a roundtable to examine the concept of Alberta Health as a Living Laboratory. The ‘Living Laboratory’ concept builds off the recognition of the unique assets and opportunity we have in Alberta, including a single health authority…
PDF of a PowerPoint presentation by Dr. Michael McGinnis, Executive Director, Roundtable on Value & Science-Driven Health Care, United States Institute of Medicine (IOM).
A "Living Laboratory" in Alberta Roundtable.
PDF of a PowerPoint presentation by Dr. Chris Henshall, Board Member, Alberta Research and Innovation Authority.
A "Living Laboratory" in Alberta Roundtable.
PDF of a PowerPoint presentation by Dr. Marvin Fritzler, Chair, Alberta Research and Innovation Authority.
A "Living Laboratory" in Alberta Roundtable.
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of the 2008 report on islet transplantation (IT) for Type 1 diabetes (T1DM). Section One of this analysis was intended to describe the profile of T1DM (definition, progression, epidemiology, and population dynamics of affected adults in Alberta, in Canada,…
| Ian Colman, Yasmin Garad, Yiye Zeng, Kiyuri Naicker, Murray Weeks, Scott Patten, Peter Jones, Angus Thompson, T. Cameron Wild
Purpose: Studies suggest that childhood trauma is linked to both depression and heavy drinking in adulthood, and may create a lifelong vulnerability to stress. Few studies have explored the effects of stress sensitization on the development of depression or heavy drinking among those who have experienced traumatic childhood events. This study aimed to determine the effect…
| Sherilyn Houle, Finlay McAlister, Cynthia Jackevicius, Anderson Chuck, Ross Tsuyuki
BACKGROUND: Pay-for-performance (P4P) is increasingly touted as a means to improve health care quality.
PURPOSE: To evaluate the effect of P4P remuneration targeting individual health careproviders.
Value for Money in the Health System was the eighth in the series of Innovation Forums. The keynote speaker, Mr. Don Drummond, Matthews Fellow and Distinguished Visiting Scholar in the School of Policy Studies at Queens University, and a former Associate Deputy Minister of Finance in the Government of Canada, as well as a former Senior Vice President and Chief Economics at TD Financial…
Value for Money in the Health System was the eighth in the series of Innovation Forums. The keynote speaker, Mr. Don Drummond, Matthews Fellow and Distinguished Visiting Scholar in the School of Policy Studies at Queens University, and a former Associate Deputy Minister of Finance in the Government of Canada, as well as a former Senior Vice President and Chief Economics at TD Financial…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report performs an evaluation of the scientific evidence on the safety, performance, and effectiveness of universal and targeted preschool hearing screening (PHS) to inform the Infant and Preschool Screening Framework being developed by the Community and Public Health (CPH)…
Stroke Update 2012 was a free forum for primary care clinicians, held in conjunction with the annual Accelerating Primary Care conference in Banff, Alberta, November 18, 2012. The forum brought together 5 physician leaders to review the current “state of the art” in the rapidly advancing field of stroke prevention and care, with an emphasis on the role of primary care.…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This review focused on the best evidence available on the use of PSVS to detect vision conditions in asymptomatic preschool children (aged from birth to 6 years; not necessarily considered at risk for developing visual impairment) to determine the safety and efficacy/effectiveness…
The EQ-5D is a standardized instrument developed by the EuroQol group for use as a measure of health outcome. It considers five dimensions of health-related quality of life: mobility, self-care, usual activities, pain/discomfort, anxiety/depression. When the need for greater collaboration around implementation and use of the EQ-5D in Alberta was recognized in eary 2012, colleagues…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of a 2007 report. Permanent congenital hearing impairment/loss (PCHI/PCHL) is one of the most common congenital anomalies found at birth which can lead to delays and deficits in the development of speech, language, cognition, and learning, as well as…
This project is concerned with describing a comprehensive set of HTA products, not the methods used to produce them. The report describes various products produced by HTA agencies and provides a summary of the basic elements of these products, but an in-depth analysis of, or comparison between, the various products in terms of their methodology is beyond its scope. Information…
Background: The aim of this study was to extend an earlier retrospective cohort study of schizophrenia via a prospective study to a follow-up of 34 years, with an emphasis on describing the life-course of the illness.
| Thanh Nguyen, Anderson Chuck, Arto Ohinmaa, Philip Jacobs
Background: The benefits of pharmaceutical innovations are widely diffused; they accrue to the healthcare providers, patients, employers, and manufacturers. We estimate the societal monetary benefits of simvastatin in Canada and its distribution among different beneficiaries overtime.
| Mel Slomp, Philip Jacobs, Arto Ohinmaa, Roger Bland, Ray Block, Carolyn Dewa, Carina Wang
OBJECTIVES: In Canada, most mental health services are embedded in the publichealth care system. Little is known of the cost distribution within the mental healthpopulation. Our study aims to estimate the depression care costs of patients with adepression diagnosis, ranking them by the increasing total depression health carecosts.
| Logan McLeod, JoAnn Kingston-Riechers, Egon Jonsson
Abstract: The potential risks to patient safety in a primary care setting are different than the risks to patient safety in an acute care setting. The main differences arise from the organisational structures of primary care delivery and the greater involvement of patients in their care. To account for these differences, we present the Patient Safety in Primary Care Framework…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report provides an epidemiological profile of fetal aneuploidy and open neural tube defects (ONTD); describes the patterns of care, utilization trends, and factors affecting the provision of first and second trimester screening (FASTs) services for fetal aneuploidy and…
This background document outlines the methods used to update the Alberta Clinical Practice Guideline (CPG) for the Evidence-Informed Primary Care Management of Low Back Pain, which was produced as part of the second phase of the Alberta Health Technology Assessment (HTA) Ambassador Program.
Link to Alberta Ambassador Guideline Adaptation Program
The concept of “personalized medicine” in health is garnering increased attention. Personalized medicine can be defined as the tailoring of preventive, diagnostic, or therapeutic interventions to the characteristics of an individual or population. This may involve genetic or laboratory biomarker information. As personalized medicine promises to increasingly change the…
For which strategies of suicide prevention is there evidence of effectiveness? This report aims to synthesize research findings from existing systematic reviews to address two questions: What types of preventive interventions have been evaluated in the published literature? Which strategies have good-quality evidence to support them? Limited evidence - as well as variability by…
Primary Care Management of Headache in Adults1st edition, July 2012Guideline Documents including Full Guideline (Hosted by Towards Optimized Practice (TOP) Alberta)
The guideline was developed as part of the Alberta Ambassador Guideline Adaptation Program (http://www.ihe.ca/research-programs/hta/aagap)
| Sherilyn Houle, Anderson Chuck, Finlay McAlister, Ross Tsuyuki
STUDY OBJECTIVE: To quantify the potential cost savings of a community pharmacy-basedhypertension management program based on the results of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN) study in terms of avoided cardiovascular events-myocardial infarction, stroke, and heart failure hospitalization, and to compare these cost savings…
PDF of a PowerPoint presentation by Sir Michael Marmot, Director, Institute of Health Equity and MRC Research Professor in Epidemiology, University College London.
IHE Innovation Forum VII – Social Determinants of Health
Social Determinants of Health is the seventh IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
| Bach Tran, Arto Ohinmaa, Anh Duong, Nhan Do, Long Nguyen, Quoc Nguyen, Steve Mills, Philip Jacobs, Stan Houston
PURPOSE: This longitudinal study assessed the changes in drug use patterns and health-related quality of life (HRQL) among HIV-positive drug users in the first methadonemaintenance treatment (MMT) cohort in Vietnam.
| Paula Corabian, Dagmara Chojecki, Christa Harstall
This exploratory report provides a summary of some of the published information on the current status of research in and potential future sphere of activity of nanomedicine (Part I) and an inventory of resources on nanotechnology and nanomedicine (Part II). Over the next 5 to 10 years it is expected that the overall impact of nanomedicine will be multifaceted, with significant…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report summarizes available key information on the use of bariatric treatments for adult obesity in Alberta and North America (mainly Canada). This analysis was intended to describe the profile of adult obesity (definition, progression, epidemiology, and population dynamics…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the research evidence on the safety and efficacy of insulin pump therapy, as compared to multiple daily insulin injections, in the treatment of children, adults, and pregnant women diagnosed with type 1 diabetes. The report also analyses the economic impact…
| Carmen Moga, Bing Guo, Don Schopflocher, Christa Harstall
This Methodology Paper summarizes the process, a modified Delphi approach, used to develop a specific checklist for the quality appraisal of case series studies. This work was supplemented with a review of other published checklists and an initial pilot test of the newly developed quality appraisal checklist. Researchers at the Institute of Health Economics with researchers from…
| Anne-Marie Boström, Susan E Slaughter, Dagmara Chojecki, Carole Estabrooks
OBJECTIVES: The recent emphasis on knowledge translation (KT) in health care is based on the premise that quality of care improves when research findings are translated into practice. This study aimed to identify the extent, nature, and settings of KT research pertaining to the care of older adults.
This report describes a framework for evaluating policies developed within the Alberta Health Technologies Decision Process (AHTDP) to strengthen the link between policy development and evidence. The framework was designed as a foundation upon which to build a more detailed and contextualized evaluative process in consultation with all stakeholders who are likely to be affected…
In February 2012, the Canadian Institute for Health Information (CIHI) in partnership with the Institute of Health Economics (IHE) sponsored a two day meeting of content, administrative and research experts to identify the breadth of diagnostic imaging studies that CIHI might feasibly undertake with its data or with data that could be easily obtained. The purpose of this report…
Sponsored by the Institute of Health Economics (IHE) – Methodology Forum Series. Presented at the Health Canada and Canadian Institutes of Health Research Personalised Medicine in Canada: A Multi-Stakeholder Workshop to Examine the Canadian Perspective, January 12, 2012. The specific objectives of this session/workshop were to: Explore issues relevant to economic evaluation…
| Bing Guo, Christa Harstall, Thomas Louie, Sander Veldhuyzen van Zanten, Levinus Dieleman
Aim: To critically appraise the clinical research evidence on the safety and effectiveness of FT compared with standard care in the treatment of patients with CDAD.
From the Introduction: Until four or five decades ago, the clinical consensus about childhood depression was that it did not, and perhaps could not, occur (Lefkowitz & Burton, 1978; Rie, 1966; Rochlin, 1965; Wolfenstein, 1966). In fact, prior to 1960, childhood depression was rarely mentioned in the literature (Cytryn, 2003; Tisher, 2007). A number of studies and conceptualizations…
| Carissa Escober-Doran, Philip Jacobs, Carolyn Dewa
This study measures the return on investment for parent training at the pre- or early childhood stage. The purpose is to prevent conduct disorders in childhood, and mental health problems in adolescence and adulthood. The program studied is the Triple P program. The context is a one year birth cohort in Alberta. The costs are for a universal parental training program. The downstream…
| Philip Jacobs, Jessica Moffatt, Arto Ohinmaa, Egon Jonsson
Background: To address public health risk factors, governments conduct interventions in many different ministries, including non-health ministries. In order to understand the scope and cost of public health in Alberta, we developed a survey of government public health interventions. We included any government ministry or public organization, which includes health as a stated…
OBJECTIVE: About one-third of the annual $51 billion cost of mental illnesses is related to productivity losses. However, few studies have examined the association of treatment and productivity. The purpose of our research is to examine the association of depression and its treatment and work productivity.
Maximizing Health System Performance—Assisted by Evidence, Science, and Information Systems is the sixth of the IHE’s Innovation Forums, a semi-annual series brings together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system, not just in Alberta, but to all of Canada and the international community, as well.
Maximizing Health System Performance—Assisted by Evidence, Science, and Information Systems is the sixth of the IHE’s Innovation Forums, a semi-annual series brings together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system, not just in Alberta, but to all of Canada and the international community, as well.
PDF of a PowerPoint presentation by Dr. Martin McKee, Professor, European Public Health, London School of Hygiene and Tropical Medicine.
IHE Innovation Forum VI – Maximizing Health System Performance: Assisted by Evidence, Science and Information Systems
PDF of a PowerPoint presentation by Ms. Terhilda Garrido, Vice President HiT Transformation and Analytics, Kaiser Permanente.
IHE Innovation Forum VI – Maximizing Health System Performance: Assisted by Evidence, Science and Information Systems
The Institute of Health Economics organized the November 17 roundtable, with funding from Merck and in-kind support from the Canadian Health Services Research Foundation. The roundtable served as an initial gathering of the original partners and invited delegates (see Appendix I for full participant list) to further develop the HCiC partnership and begin planning…
Evidence-Informed Primary Care Management of Low Back Pain2nd edition, November 2011Guideline Documents including Full Guideline (Hosted by Towards Optimized Practice (TOP) Alberta)
The guideline was developed as part of the Alberta Ambassador Guideline Adaptation Program (http://www.ihe.ca/research-programs/hta/aagap)
Abstract: In the 1980s, drug prices began rising considerably worldwide, and in the 1990s, countries began incorporating health economics into the scientific review process. Rising prices in vaccines began around the year 2000 and national bodies began to use health economics to review vaccines in the next decade. Health economics is a discipline that evaluates alternative…
The Alberta Diabetes Surveillance System (ADSS) was created in 2006 in partnership with Alberta Health and Wellness (AHW) and the Institute of Health Economics (IHE). The purpose of the ADSS is to provide information about diabetes within the province of Alberta. This information includes the incidence, prevalence and use of health care services for people with diabetes, along…
Purpose: The concept of the suicidal process implies a progression from behaviour of relatively low intent to completed suicide. Evidence from the literature has given rise to the speculation that the age of onset of an early form of the suicidal process may be associated with the ultimate seriousness of suicidal behaviour. This study was designed to test the hypothesis…
| Philip Jacobs, Jessica Moffatt, Egon Jonsson, Arto Ohinmaa, Cathy Gladwin
The Institute of Health Economics (IHE) has completed a scan to determine what public health-related costs are borne by government departments, ministries, and agencies. The final report, Everybody’s Business: The Cost of Multi-Department Involvement in Public Health in Alberta, was funded by Alberta Health Services (AHS) as part of the Project 2030 initiative that saw the…
| Christa Harstall, Paul Taenzer, Donna Angus, Carmen Moga, Ann Scott, Tara Schuller
Rationale, Aims, and Objectives: A collaborative, multidisciplinary guideline adaptation process was developed to construct a single overarching, evidence-based clinical practice guideline (CPG) for all primary care practitioners responsible for the management of low back pain (LBP) to curb the use of ineffective treatments and improve patient outcomes. Note: This is an…
The Alberta Survey of Addictive Behaviours and Mental Health in the Workforce: 2009 is the third such study conducted since 1992. It provides an interesting, comprehensive picture of many issues related to the mental health of workers across all sectors in Alberta. Introduction IHE is pleased to release the final report of The Alberta Survey of Addictive Behaviours and Mental Health…
This report describes the outcomes of a two day workshop that explored options for improving quality and access to diagnostic imaging services for low back pain (LBP) in Alberta through the engagement of stakeholders that are involved in the assessment, diagnosis, treatment, and management of this condition. These include health professionals, health service managers, administrators,…
As part of Alberta Health Services (AHS) Strategic Health Needs Assessment and Service Design 2030 project, “Becoming the Best: Building Sustainability” the Institute of Health Economics (IHE) was commissioned to conduct three Knowledge Exchange events between February and May 2011. These single-day conferences assembled leading international thinkers and experts in…
This one-day, invitational event engaged community experts and senior decision-makers involved in First Nations, Inuit, and Métis health policy in Canada in round-table discussions. Integrated Knowledge Exchange in health requires communities, researchers, and policy-makers utilize evidence from all sources in a culturally relevant way.
As part of Alberta Health Services (AHS) Strategic Health Needs Assessment and Service Design 2030 project, the Institute of Health Economics was commissioned to conduct three Knowledge Exchange events. The third event – Population Health Innovations – was held May 2nd, 2011. The event was supported by Alberta Health Services in collaboration with Alberta Health and…
PDF of a PowerPoint presentation by Dr. Lynne Friedli, Mental Health Promotion Specialist.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Population Health Innovations Conference
PDF of a PowerPoint presentation by Dr. Nancy Edwards, Professor, School of Nursing, University of Ottawa; Principal Scientist, Institute of Public Health; Senior Scientist, Élisabeth Bruyére Research Institute; Award Holder, CIHR/CHSRF Chair Award in Nursing. Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Population Health Innovations…
PDF of a PowerPoint presentation by Dr. Phil Jacobs, Professor, Health Economics, Department of Medicine, University of Alberta; Research Economist, Institute of Health Economics.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Population Health Innovations Conference
PDF of a PowerPoint presentation by Dr. Cordell Neudorf, Chief Medical Health Officer, Saskatoon Health Region; Chair, Canadian Public Health Association.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Population Health Innovations Conference
PDF of a PowerPoint presentation by Dr. Patricia Martens, Professor, Faculty of Medicine, University of Manitoba; Director, Manitoba Centre for Health Policy.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Population Health Innovations Conference
PDF of a PowerPoint presentation by Dr. Lennert Veerman, Senior Research Fellow, Centre for Burden of Disease and Cost-Effectiveness, School of Public Health, University of Queensland.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Population Health Innovations Conference
PDF of a PowerPoint presentation by Dr. Nadine Burke, Medical Director, Bayview Child Health Center, California Pacific Medical Center.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Population Health Innovations Conference
PDF of a PowerPoint presentation by Dr. Gerry Predy, Senior Medical Officer of Health, Alberta Health Services.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Population Health Innovations Conference
PDF of a PowerPoint presentation by Dr. Kim Raine, Professor, School of Public Health, University of Alberta.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Population Health Innovations Conference
PDF of a PowerPoint presentation by Mr. Riel Miller, Futurist, XperidoX: Futures Consulting.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Population Health Innovations Conference
PDF of a PowerPoint presentation by Dr. Tom Noseworthy, Director, Centre for Health and Policy Studies, Department of Community Health Sciences, University of Calgary.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Population Health Innovations Conference
This in-depth book contains an introduction to prevention of FASD and to the different methods that are used. There is also a systematic review of the effectiveness of prevention approaches and an overview of reviews on FASD. The book ends with a chapter called “Five perspectives on prevention of FASD” written by professionals in the field who are working to prevent…
As part of Alberta Health Services (AHS) Strategic Health Needs Assessment and Service Design 2030 project, the Institute of Health Economics was commissioned to conduct three Knowledge Exchange events. The second event – High Performing Health Systems – was held April 15th, 2011. The event was supported by Alberta Health Services in collaboration with Alberta Health…
PDF of a PowerPoint presentation by Dr. Ellen Nolte, Director, Health and Healthcare Policy Programme, RAND Europe.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - High Performing Health Systems Conference
PDF of a PowerPoint presentation by Mr. Christophe André, Economist, Organization for Economic Cooperation and Development.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - High Performing Health Systems Conference
PDF of a PowerPoint presentation by Prof. Chris Ham, The King's Fund.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - High Performing Health Systems Conference
PDF of a PowerPoint presentation by Prof. Guus Schrijvers, Professor of Public Health, Julius Center for Health Sciences and Primary Care.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - High Performing Health Systems Conference
PDF of a PowerPoint presentation by Dr. Murray Ross, Vice President and Director, Kaiser Permanente Institute for Health Policy.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - High Performing Health Systems Conference
PDF of a PowerPoint presentation by Dr. Chris Wood, Intermountain Health Care.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - High Performing Health Systems Conference
PDF of a PowerPoint presentation by Mr. John Abbott, Chief Executive Officer, Health Council of Canada.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - High Performing Health Systems Conference
PDF of a PowerPoint presentation by Ms. Deborah Prowse, Patient Advocate and Board Member, Canadian Patient Safety Institute.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - High Performing Health Systems Conference
PDF of a PowerPoint presentation by Dr. Tom Noseworthy, Director, Centre for Health and Policy Studies, Department of Community Health Sciences, University of Calgary.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - High Performing Health Systems Conference
Link to a PowerPoint presentation by Dr. Reinhard Busse, Professor, Department of Health Care Management, European Observatory on Health Systems.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - High Performing Health Systems Conference
PDF of a PowerPoint presentation by Dr. Lou Garrison, Professor, Pharmaceutical Outcomes Research & Policy Program, Department of Pharmacy, and Adjunct Professor, Departments of Global Health and Health Services, University of Washington.
Innovative Industry Payer Agreements Roundtable
PDF of a PowerPoint presentation by Dr. Jorge Mestre-Ferrandiz, Senior Economist, Office of Health Economics.
Innovative Industry Payer Agreements Roundtable
PDF of a PowerPoint presentation by Dr. Chris Henshall, Chair, HTAi Policy Forum, Health Technology Assessment International.
Innovative Industry Payer Agreements Roundtable
PDF of a PowerPoint presentation by Dr. Ambrose Carrejo, National Pharmaceutical Contracting Leader, Kaiser Foundation Hospitals.
Innovative Industry Payer Agreements Roundtable
PDF of a PowerPoint presentation by Mr. Bob Nakagawa, Assistant Deputy Minister of Health, British Columbia Ministry of Health.
Innovative Industry Payer Agreements Roundtable
PDF of a PowerPoint presentation by Dr. Brian Cuffel, Senior Director, Global Market Access, Pfizer Inc.
Innovative Industry Payer Agreements Roundtable
PDF of a PowerPoint presentation by Mr. Edward Godber, Head, European Union Access to Medicines, GlaxoSmithKline.
Innovative Industry Payer Agreements Roundtable
This one-day, invitational event engaged community experts and senior decision-makers involved in First Nations, Inuit, and Métis health policy in Canada in round-table discussions. Integrated Knowledge Exchange in health requires communities, researchers, and policy-makers utilize evidence from all sources in a culturally relevant way.
PDF of PowerPoint Presentation by Dr. Judy Bartlett; Manitoba Metis Federation.
Aboriginal Peoples’ Wellness in Canada: Scaling Up the Knowledge Roundtable
PDF of a PowerPoint Presentation by Dr. Dawn Martin-Hill; McMaster University.
Aboriginal Peoples’ Wellness in Canada: Scaling Up the Knowledge Roundtable
PDF of a PowerPoint Presentation by Dr. Carol Hopkins; Native Addictions Partnership Foundation.
Aboriginal Peoples’ Wellness in Canada: Scaling Up the Knowledge Roundtable
PDF of a PowerPoint Presentation by Dr. Margaret Akan; All Nation's Hope AIDS Network.
Aboriginal Peoples’ Wellness in Canada: Scaling Up the Knowledge Roundtable
PDF of a PowerPoint Presentation by Dr. Jeff Reading; University of Victoria.
Aboriginal Peoples’ Wellness in Canada: Scaling Up the Knowledge Roundtable
PDF of a PowerPoint Presentation by Dr. John O'Neil; Simon Frasier University.
Aboriginal Peoples’ Wellness in Canada: Scaling Up the Knowledge Roundtable
PDF of a PowerPoint Presentation by Dr. Evan Adams; Aboriginal Physician Advisor.
Aboriginal Peoples’ Wellness in Canada: Scaling Up the Knowledge Roundtable
This one-day, invitational event engaged community experts and senior decision-makers involved in First Nations, Inuit, and Métis health policy in Canada in round-table discussions. Integrated Knowledge Exchange in health requires communities, researchers, and policy-makers utilize evidence from all sources in a culturally relevant way.
| Bing Guo, Christa Harstall, Thanh Nguyen, Arto Ohinmaa
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). Fecal transplantation for the treatment of Clostridium difficile-associated disease or ulcerative colitis examines the clinical research evidence on the safety and effects of fecal transplantation in the treatment of patients with Clostridium difficile-associated disease…
A National Roundtable Discussion on Innovative Approaches to Industry-Payor Agreements took place on April 3th, 2011 at the Fairmont Hotel Vancouver in Vancouver, British Columbia in association with the annual meeting of the Canadian Agency for Drugs and Technologies in Health (CADTH). This one-day invitational event engaged experts, industry leaders and senior decision makers…
The purpose of this paper is to provide background information on "game changing innovations" in support of the February 24, 2011 conference Becoming the Best: Building a Sustainable Health System – Game Changing Health Innovations. It was developed by the Institute of Health Economics and funded by Alberta Health Services (AHS) as part of a future focused analysis of the…
As part of Alberta Health Services (AHS) Strategic Health Needs Assessment and Service Design 2030 project, the Institute of Health Economics was commissioned to conduct three Knowledge Exchange events. The first of the Knowledge Exchange events – Becoming the Best: Building Sustainability – Game Changing Health Innovations – was held on February 24th, 2011.
PDF of a PowerPoint presentation by Dr. John Rapoport, Institute of Health Economics.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Game Changing Health Innovations Conference
PDF of a PowerPoint presentation by Dr. Robert Brook, Distinguished Chair, RAND Corporation.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Game Changing Health Innovations Conference
PDF of a PowerPoint presentation by Mr. Myles Ayling, Director of Innovation and Service Improvement, Commissioning and System Management Directorate, National Health Service.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Game Changing Health Innovations Conference
PDF of a PowerPoint presentation by Dr. Axel Meisen, Chair of Foresight, Alberta Innovates – Technology Futures.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Game Changing Health Innovations Conference
PDF of a PowerPoint presentation by Dr. Cliff Goodman, Senior Vice President and Principal, The Lewin Group, Vice-President Health Technology Assessment International.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Game Changing Health Innovations Conference
PDF of a PowerPoint presentation by Dr. Jeffrey Lerner, President and Chief Executive Officer, ECRI Institute.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Game Changing Health Innovations Conference
PDF of a PowerPoint presentation by Ms. Pamela Larson, Director, Consumer Health, kp.org, Kaiser Permanente.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Game Changing Health Innovations Conference
PDF of a PowerPoint presentation by Mr. Bill Trafford, Senior Vice President, Corporate Merger and Information Technology, Alberta Health Services.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Game Changing Health Innovations Conference
PDF of a PowerPoint presentation by Dr. Stephen Birch, Professor, Department of Clinical Epidemiology & Biostatistics, Centre for Health Economics and Policy Analysis, McMaster University.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Game Changing Health Innovations Conference
PDF of a PowerPoint presentation by Dr. Tom Noseworthy, Director, Centre for Health and Policy Studies, Department of Community Health Sciences, University of Calgary.
Alberta Health Services - Becoming the Best: Building a Sustainable Health System - Game Changing Health Innovations Conference
This article is an overview of systematic reviews reporting on the efficacy/effectiveness of psychotherapy and/or pharmacotherapy interventions delivered within Sex Offender Treatment (SOT) programs to reduce the risk of re-offending in convicted adult male sex offenders.
Related Report:
Treatment for Convicted Adult Male Sex Offenders
The IHE has produced a book of the proceedings from the Consensus Development Conference: FASD - Across the Lifespan. Hardcover copies are available for purchase at a unit cost of $25.00 CAD plus $2.50 shipping and handling. Click on the Add to Cart button at the bottom of this page to proceed with your purchase. In followup to the conference, the Institute has produced two…
Objective: To ascertain knowledge gaps in the diagnosis and treatment of acute and chronic low back pain (LBP) in the primary care setting to prepare a scoping survey for identifying knowledge gaps in LBP management among Alberta's primary care practitioners, and to identify potential barriers to implementing a multidisciplinary LBP guideline. Note: This is an Alberta Ambassador…
PDF of a PowerPoint presentation by Mr. Chris Mazurkewich, Executive Vice President and Chief Financial Officer, Alberta Health Services.
Funding Models to Support Quality and Sustainability – A Pan-Canadian Dialogue
PDF of a PowerPoint presentation by Mr. Les Vertesi, Executive Director, B.C. Health Services Purchasing Organization.
Funding Models to Support Quality and Sustainability – A Pan-Canadian Dialogue
PDF of a PowerPoint presentation by Mr. Kevin Empey, President and Chief Executive Officer, Lakeridge Health Corporation.
Funding Models to Support Quality and Sustainability – A Pan-Canadian Dialogue
PDF of a PowerPoint presentation by Dr. Lynn Stevenson, Executive Vice President, People, Organizational Development, practice and Chief Nurse, Vancouver Island Health Authority.
Funding Models to Support Quality and Sustainability – A Pan-Canadian Dialogue
PDF of a PowerPoint presentation by Dr. Jason Sutherland, Assistant Professor, School of Population and Public Health, University of British Columbia, and Faculty, UBC Centre for Health Services and Policy Research.
Funding Models to Support Quality and Sustainability – A Pan-Canadian Dialogue
PDF of a PowerPoint presentation by Dr. Reinhard Busse, Berlin University of Technology and the WHO European Observatory on Health Systems and Policy.
Funding Models to Support Quality and Sustainability – A Pan-Canadian Dialogue
PDF of a PowerPoint presentation by Mr. Martin Campbell (United Kingdom), Deputy Director, Payment by Results (PbR) Development, Department of Health, National Health System.
Funding Models to Support Quality and Sustainability – A Pan-Canadian Dialogue
PDF of a PowerPoint presentation by Dr. Peter McNair (Australia), Associate Director and Clinical Epidemiologist, Palo Alto Medical Foundation Research Institute and Visiting Fellow.
Funding Models to Support Quality and Sustainability – A Pan-Canadian Dialogue
PDF of a PowerPoint presentation by Dr. Murray Ross (United States), Vice President, Kaiser Foundation Health Plan Inc., Kaiser Permanente Institute for Health Policy.
Funding Models to Support Quality and Sustainability – A Pan-Canadian Dialogue
| Angus Thompson, Stephen Newman, Helene Orn, Roger Bland
OBJECTIVE: Life course studies of schizophrenia that have used a 3-phase model (onset,course, and outcome) have had their use restricted owing to differences in definition and methodology. The purpose of this investigation was to describe life course data in mathematical terms and to compare the results with the findings from other life course studies.
On September 23rd and 24th, 2010, the Institute of Health Economics conducted an Inaugural IHE Methodology Forum: Prioritizing Methodological Research in Evaluation of Health Technologies. Delegates from academia, government, industry and other stakeholders involved in the production and use of evidence were brought together to discuss methodological challenges in…
Reflecting the recent increased public awareness of the topic, this is the first and most comprehensive resource for over a decade on the molecular basis, prevalence, treatment options, socioeconomic impact, and prevention strategies of FASD. Edited by world-renowned experts, this compendium includes the latest research results to provide new insights and realistic estimations…
Abstract: Within the school system, children with mental illness receive a variety of services that arise because of their conditions, and that require resources that exceed those provided to other students. Some of these services fall into the category of "specialized mental health" services, while others are additional services provided by teachers as part of their routine activities.…
PDF of a PowerPoint presentation by Sharon Straus, Professor, Department of Medicine, Director, KT Program, Department of Medicine, University of Toronto.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Arvelle Balon-Lyon, Toward Optimized Practice (TOP), Edmonton, Alberta.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Donald Dick, Bone & Joint Clinical Network, Alberta Health Services, Edmonton, Alberta.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Y. Raja Rampersaud, MD, FRCS(C), President Canadian Spine Society, Associate Professor, Divisions of Orthopedic and Neurosurgery, University Toronto, Canada.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Gwen Friedrich, Director Research and Clinical Pathway Development, Saskatchewan Ministry of Health, and Jim Slater, Executive Director of Diagnostics, Regina Qu'Appelle Health Region.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Gwen Friedrich, Director Research and Clinical Pathway Development, Saskatchewan Ministry of Health.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Sharon Straus, Professor, Department of Medicine, Director, KT Program, Department of Medicine, University of Toronto.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation given by Chris Spanswick, Medical Director, Calgary Pain Program Alberta Health Services, Calgary Area.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Sharon E. Straus, MD MSc FRCPC, Professor, Department of Medicine, Director, KT Program, University of Toronto.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Lynn Cooper, President, Canadian Pain Coalition.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Adrian R. Gretton, MD, FCFP, CIME, Family Physician in Community Practice, Consultant, Chronic Pain Centre, Calgary.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Robert Lambert, Chair of Radiology and Diagnostic Imaging, University of Alberta.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by John You, Assistant Professor, Department of Medicine, McMaster University.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Thomas E. Feasby, MD, Dean, Faculty of Medicine, University of Calgary.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Bill Anderson, Edmonton Zone Clinical Director, Alberta Health Services and Mauro Chies, Vice President, Diagnostic Imaging Services, Alberta Health Services.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Gwendolyn Friedrich, Director Research and Clinical Pathway Development, Saskatchewan Ministry of Health.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Tai Huynh, Director, Excellent Care for All Strategy, Ministry of Health and Long-Term Care.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Christa Harstall, Director, Health Technology Assessment, Institute of Health Economics, Paul Taenzer, Consultant, and Chris Spanswick, Medical Director, Calgary Pain Program Alberta Health Services, Calgary Area.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
On October 26 & 27, 2010, the Institute of Health Economics (IHE) conducted an invitational workshop on the optimal use of diagnostic imaging (CT and MRI) based on the recommendations from the low back pain guideline.
Diagnostic Imaging Workshop – as part of the Alberta Ambassador Guideline Adaptation Program
Emceed by Don Newman, national journalist and broadcaster and Chair of Canada 2020, this fifth session considered the following theme: Innovation and Sustainability in Health Systems. Speakers from all sectors provided a range of perspectives on how to foster innovation and drive towards a more sustainable healthcare system.
PDF of remarks from a presentation by Dr. Alexandra Bibbee, senior health economist from the Organization of Economic Cooperation and Development (OECD).
IHE Innovation Forum V - Innovation and Sustainability in Health Systems
PDF of remarks from a presentation by Ms. Alison Tonge, Executive Vice-President of Alberta Health Services.
IHE Innovation Forum V - Innovation and Sustainability in Health Systems
| Carissa Escober-Doran, Philip Jacobs, Carolyn Dewa
Objective: In Canada charitable or nonprofit organizations provide government-contracted mental health and addictions services, and they augment government funding by raising charitable revenues. This study estimated by source the revenues of nonprofit mental health and addictions organizations in Canada.
PDF of a PowerPoint presentation by Mr. Larry Svenson, Senior Manager, Epidemiology and Surveillance, Alberta Health and Wellness.
Prioritizing Methodological Research in the Evaluation of Health Technologies in Canada
PDF of a PowerPoint presentation by Dr. Philip Jacobs, Professor, Faculty of Medicine and Dentistry, University of Alberta; Director of Collaborations, Institute of Health Economics.
Prioritizing Methodological Research in the Evaluation of Health Technologies in Canada
PDF of a PowerPoint presentation by Dr. Stirling Bryan, Professor, Department of Medicine, University of British Columbia; Director, Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute.
Prioritizing Methodological Research in the Evaluation of Health Technologies in Canada
PDF of a PowerPoint presentation by Dr. Stuart Peacock, Co-Director, Canadian Centre for Applied Research in Cancer Control; Senior Scientist, British Columbia Cancer Agency; Associate Professor, University of British Columbia.
Prioritizing Methodological Research in the Evaluation of Health Technologies in Canada
PDF of a PowerPoint presentation by Dr. Deborah Marshall, Associate Professor, Department of Community Health Sciences, Faculty of Medicine, University of Calgary; Canada Research Chair, Health Services and Systems Research; Director, Health Technology Assessment, Alberta Bone and Joint Health Institute. Prioritizing Methodological Research in the Evaluation of Health Technologies…
PDF of a PowerPoint presentation by Dr. Braden Manns, Associate Professor, Faculty of Medicine, University of Calgary.
Prioritizing Methodological Research in the Evaluation of Health Technologies in Canada
PDF of a PowerPoint presentation by Dr. Marc Berger, Vice President, Global Health Outcomes, Eli Lilly and Company.
Prioritizing Methodological Research in the Evaluation of Health Technologies in Canada
PDF of a PowerPoint presentation by Dr. Michael Drummond, Professor of Health Economics, University of York.
Prioritizing Methodological Research in the Evaluation of Health Technologies in Canada
Advancements in methodological approaches in the evaluation of health technologies are important for ensuring ongoing improvement in the comprehensiveness and quality of assessments. On September 23 and 24th, 2010, The Institute of Health Economics (IHE) conducted an invitational methodology forum addressing the economic evaluation of medicines in Canada. Delegates from academia,…
PDF of a PowerPoint presentation by Dr. Michael Drummond, Professor of Health Economics, University of York.
Prioritizing Methodological Research in the Evaluation of Health Technologies in Canada
PDF of a PowerPoint presentation by Dr. Mark Sculpher, Director, Economic Evaluation and Health Technology Assessment, University of York.
Prioritizing Methodological Research in the Evaluation of Health Technologies in Canada
PDF of a PowerPoint presentation by Dr. Chris Henshall Chair, HTAi Policy Forum, Health Technology Assessment International.
Prioritizing Methodological Research in the Evaluation of Health Technologies in Canada
| Philip Jacobs, Jessica Moffatt, John Rapoport, Neil Bell
This overview provides an analysis of the economic landscape of primary care in Alberta and a discussion of the proposed reforms in terms of ends and means.
IHE In Your Pocket 2010 provides current health economic statistics, presented in separate sections on health care resources, health behaviours, health status and demographics, and health system performance.
To access the IHE PowerPoint chartpack, please click the following link: IHE PowerPoint Slides.
| Thanh Nguyen, Philip Jacobs, Margaret Wanke, Ann Hense, Reg Sauve
OBJECTIVE: In 2004, the three-module, three-year long patient safety program, Managing Obstetrical Risk Efficiently (MOREOB), was introduced to all clinicians providing obstetrical services in Alberta. We report on an outcomes evaluation of this initiative.
This health technology assessment report is an overview of systematic reviews reporting on the efficacy/effectiveness of psychotherapy and/or pharmacotherapy interventions delivered within Sex Offender Treatment (SOT) programs to reduce the risk of re-offending in convicted adult male sex offenders.
Information Specialist: Liz Dennett
In order to better understand Mental Health & Addictions in the Workplace, the PNWER Health Care Working Group hosted a half day session in conjunction with the annual PNWER summit. This session brought together key policy experts, decision makers, clinicians, and business leaders, and provided the opportunity for dialogue around this issue.
PDF of a PowerPoint presentation by Dr. Ian Arnold, Chair, Workplace Committee – Canada Mental Health Commission.
Mental Health and Addiction in the Workplace 2010 Symposium
PDF of a PowerPoint presentation by Dr. Mark Attridge, President, Attridge Consulting, Inc. (Minneapolis, MN USA).
Mental Health and Addiction in the Workplace 2010 Symposium
PDF of a PowerPoint presentation by Dr. Angus Thompson, Researcher, Institute of Health Economics (Edmonton, AB Canada).
Mental Health and Addiction in the Workplace 2010 Symposium
PDF of a PowerPoint presentation by Dr. JianLi Wang, Associate Professor, Psychiatry & Community Health, University of Calgary (Calgary, AB Canada).
Mental Health and Addiction in the Workplace 2010 Symposium
PDF of a PowerPoint presentation by Dr. Merv Gilbert, Partner, Gilbert Acton Ltd. (Vancouver, BC Canada).
Mental Health and Addiction in the Workplace 2010 Symposium
PDF of a PowerPoint presentation by Mr. Chris Hylton, Principal, Hylton & Associates (Calgary, AB Canada).
Mental Health and Addiction in the Workplace 2010 Symposium
PDF of a PowerPoint presentation by Dr. Ann Malain, Regional Director and Practice Lead Substance Abuse Services, Human Solutions (Toronto, Canada).
Mental Health and Addiction in the Workplace 2010 Symposium
PDF of a PowerPoint presentation by Dr. Mark Attridge, President, Attridge Consulting, Inc. (Minneapolis, MN USA).
Mental Health and Addiction in the Workplace 2010 Symposium
Abstract: The article presents information on the Health Technology Assessment. Guidance for health care practices in Sweden were documented when Medical Collegium was established in 1663 to distinguish quackery from medicine and control the poisonous drugs. In early 1980s, Sweden established the Swedish Council on Technology Assessment in Healthcare to assess major diseases…
| Amanda Burls, Lorraine Caron, Ghislaine Cleret de Langavant, Wybo Dondorp, Christa Harstall, Ela Pathak-Sen, Bjørn Hofmann
OBJECTIVES: Values are intrinsic to the use of health technology assessments (HTAs) inhealth policy, but neglecting value assumptions in HTA makes their results appear more robust or normatively neutral than may be the case. Results of a 2003 survey by the International Network of Agencies for Health Technology Assessment (INAHTA) revealed the existence of disparate methods…
This background document outlines the methods used to develop the Alberta Clinical Practice Guideline (CPG) for the Evidence-Informed Primary Care Management of Low Back Pain, which was produced as part of the second phase of the Alberta Health Technology Assessment (HTA) Ambassador Program.
Link to Alberta Ambassador Guideline Adaptation Program
| Arto Ohinmaa, Trish Chatterley, Thanh Nguyen, Philip Jacobs
This report reviews the evidence of telehealth in substance abuse and addiction including the literature on smoking, alcohol, drug abuse and gambling. The included telehealth technologies include videoconferencing, computer, Internet, and telephone.
The economic impact of mental illness and addictions is felt throughout society - in the health care system, the social services system, education, criminal justice, and the workplace. In this booklet we conducted a provincial and national level analysis of the expenditures on mental health and addictions in Canada.
Emceed by Tom Feasby, the University of Calgary‘s Dean of Medicine, this fourth session considered the following theme: Innovation and Economics: Investing in the Future Health System. Speakers from all sectors provided a range of perspectives on the best ways to direct resources so as to ensure a real return on investment.
PDF of a PowerPoint presentation by Dr. Marvin Fritzler, Chair, Alberta Research and Innovation Authority.
IHE Innovation Forum IV - Innovation and Economics: Investing in the Future Health System
PDF of a PowerPoint presentation by Dr. Adam Elshaug, Senior Lecturer, University of Adelaide.
Note: This material is the copyright of Dr. Adam Elshaug and is not to be reproduced without his express consent and with full reference given.
IHE Innovation Forum IV - Innovation and Economics: Investing in the Future Health System
PDF of remarks from a presentation by Dr. Stephen Duckett, CEO, Alberta Health Services.
IHE Innovation Forum IV - Innovation and Economics: Investing in the Future Health System
PDF of a PowerPoint presentation by Dr. Bernard Prigent, Vice-President, Pfizer Canada and IHE Board Member.
IHE Innovation Forum IV - Innovation and Economics: Investing in the Future Health System
PDF of a PowerPoint presentation by Dr. Pierre-Thomas Leger, Associate Professor of Economics at HEC Montréal where he holds the Professorship in Health Economics.
Provider Funding: Performance, Accountability, and Incentives Forum
PDF of a PowerPoint presentation by Dr. Meredith Rosenthal, Associate Professor of Health Economics and Policy in the Department of Health Policy and Management at the Harvard School of Public Health.
Provider Funding: Performance, Accountability, and Incentives Forum
PDF of a PowerPoint presentation by Dr. Anne Sales, Associate Professor in the Faculty of Nursing, University of Alberta; Canada Research Chair in Interdisciplinary Healthcare Teams.
Provider Funding: Performance, Accountability, and Incentives Forum
PDF of a PowerPoint presentation by Mr. Richard Hamblin, Director of Intelligence at the Care Quality Commission.
Provider Funding: Performance, Accountability, and Incentives Forum
PDF of a PowerPoint presentation by Ms. Anne McFarlane, Executive Director of the Canadian Institute for Health Information in Western Canada.
Provider Funding: Performance, Accountability, and Incentives Forum
There is a wealth of theoretical and real-world evidence on the impacts of physician payment system design on physician behavior and health system performance. In order to bring some of that knowledge to Alberta the Institute of Health Economics (IHE) conducted, on behalf of Alberta Health and Wellness, a 1 and ½ day Provider Funding: Performance, Accountability, and Incentives…
PDF of a PowerPoint presentation by Dr. Owen Adams, Assistant Secretary General, Research, Policy and Ethics of the Canadian Medical Association (CMA).
Provider Funding: Performance, Accountability, and Incentives Forum
PDF of a PowerPoint presentation by Dr. Meredith Rosenthal, Associate Professor of Health Economics and Policy in the Department of Health Policy and Management at the Harvard School of Public Health.
Provider Funding: Performance, Accountability, and Incentives Forum
PDF of a PowerPoint presentation by Dr. Richard Saltman, Professor of Health Policy and Management at the Emory University School of Public Health in Atlanta, Georgia.
Provider Funding: Performance, Accountability, and Incentives Forum
PDF of a PowerPoint presentation by Mr. Richard Hamblin, Director of Intelligence at the Care Quality Commission. Mr. Hamblin presented for Mr. Tim Doran, National Primary Care Research and Develoment Centre, University of Manchester.
Provider Funding: Performance, Accountability, and Incentives Forum
The Sexual Exploitation of Children and Youth Over the Internet: A Rapid Review of the Scientific Literature report examines the research evidence on the frequency, effects, risk factors of sexual exploitation of children and youth over the Internet. The report also provides information on available resources in Alberta and Canada regarding Internet safety and prevention of child…
Part of the successful Institute of Health Economics (IHE) book series, this handbook and ready reference adopts a unique approach in combining policy recommendations with specific treatment options for Parkinson patients. The first part of the book deals with the clinical medical, social and economical aspects of Parkinson Disease. These ten chapters include the latest diagnosis…
| Deborah Marshall, Paul Rogers, Thomas Rohleder, Sonia Vanderby
This booklet provides an overview of the System Dynamics (SD) approach and its potential applications in improving access to health services and quality of care. The specific application addressed here is the improvement of care of patients with hip and knee osteoarthritis (OA), as this is a pressing issue in Canada today. The specific health system and population addressed here…
PURPOSE: A study was undertaken to evaluate the utilization rates of routine preoperativeelectrocardiogram (ECG) and chest x-ray (CXR) by sex, age, and most frequent surgery type, and to estimate the total cost of these screening tests.
The Effective Involvement of Patients in Health Technology Decisions: What Does Best Look Like? program presented some of the latest international and Canadian developments in policy in this important area. It also included presentations from experts and interactive discussion amongst the participants.
PDF of a PowerPoint presentation by Mr. John Sproule, Senior Policy Director, Institute of Health Economics.
Maximizing Patient Value – Effective Involvement of Patients in Health Technology Decisions: What Does Best Look Like?
PDF of a PowerPoint presentation by Dr. Karen Facey, Chair, HTAi Interest Sub-group: Patient and Citizen Involvement in HTA.
Maximizing Patient Value – Effective Involvement of Patients in Health Technology Decisions: What Does Best Look Like?
PDF of a PowerPoint presentation by Dr. Marie-Pierre Gagnon, CHUQ Research Centre, Hopital St-Francois d'Assise.
Maximizing Patient Value – Effective Involvement of Patients in Health Technology Decisions: What Does Best Look Like?
PDF of a PowerPoint presentation by Ms. Cheryl Arratton, Canadian Cochrane Network and Centre, Ottawa, Canada, Institute of Population Health.
Maximizing Patient Value – Effective Involvement of Patients in Health Technology Decisions: What Does Best Look Like?
PDF of a PowerPoint presentation by Ms. Elaine MacPhail, Canadian Agency for Drugs and Technologies on Health.
Maximizing Patient Value – Effective Involvement of Patients in Health Technology Decisions: What Does Best Look Like?
PDF of a PowerPoint presentation by Dr. George Tolomiczenko, Executive Director of Research & Scientific Liaison, Crohn's & Colitis Foundation of Canada.
Maximizing Patient Value – Effective Involvement of Patients in Health Technology Decisions: What Does Best Look Like?
| Susan E Brien, Diane Lorenzetti, Steven Lewis, James Kennedy, William A Ghali
BACKGROUND: There is an extensive body of literature on health system quality reporting that has yet to be characterized. Scoping is a novel methodology for systematically assessing the breadth of a body of literature in a particular research area. Our objectives were to showcase the scoping review methodology in the review of health system quality reporting, and to reporton…
This report on Means Restriction for Suicide Prevention provides a summary of information regarding national means restriction policies/strategies and national/provincial intentional overdose prevention policies/strategies and their effectiveness. Policies/strategies that focus on children, youth, and young adults are of particular interest. This report consists of two parts: Part…
Rationale, aims and objectives: The Appraisal of Guidelines Research and Evaluation (AGREE) instrument is a generic tool for assessing guideline quality. This feasibility study aimed to reduce the ambiguity and subjectivity associated with AGREE item scoring, and to augment the tool's capacity to differentiate between good- and poor-quality guidelines. Note: This is an Alberta…
Emceed by Tom Feasby, the University of Calgary’s Dean of Medicine, this third session considered the following theme: Maximizing Health System Performance: Cost Containment and Improved Efficiency. Speakers from all sectors provided a range of perspectives on Cost Containment and Improved Efficiency.
PDF of a PowerPoint presentation by Dr. Robert Brook, Rand Health.
IHE Innovation Forum III - Maximizing Health System Performance (1): Cost Containment and Improved Efficiency
PDF of a PowerPoint presentation by Mr. Jeff Lozon, CEO Revera Living.
IHE Innovation Forum III - Maximizing Health System Performance (1): Cost Containment and Improved Efficiency
PDF of a PowerPoint presentation by Dr. Stephen Duckett, CEO, Alberta Health Services.
IHE Innovation Forum III - Maximizing Health System Performance (1): Cost Containment and Improved Efficiency
PDF of a PowerPoint presentation by Dr. Dr. Philip Baker, Dean of Medicine, University of Alberta.
IHE Innovation Forum III - Maximizing Health System Performance (1): Cost Containment and Improved Efficiency
The Consensus Statement on Fetal Alcohol Spectrum Disorder (FASD) - Across the Lifespan was produced by a panel of experts led by the Hon. Anne McLellan, former Deputy Prime Minister of Canada. This consensus statement on fetal alcohol spectrum disorder is the product of a unique conference: The IHE Consensus Development Conference on Fetal Alcohol Spectrum Disorder - Across the…
Le présent énoncé consensuel a été préparé par un panel indépendant de professionnels de la santé et de représentants du milieu universitaire et du public en se fondant sur: les études publiées pertinentes réunies par le Comité scientifique de la conférence pour l’établissement…
The Alberta Diabetes Surveillance System (ADSS) was created in 2006 in a partnership between Alberta Health and Wellness (AHW) and the Institute of Health Economics (IHE). The purpose of the ADSS is to provide information about diabetes within the province of Alberta. This information includes the incidence, prevalence and use of health care services for people with diabetes, along…
PDF of a PowerPoint presentation by Dr. Nancy Poole, Research Associate, British Columbia Centre of Excellence for Women's Health; Research Consultant, Women and Substance Use Issues, British Columbia Women's Hospital.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Ms. Nancy Whitney, Clinical Director, King County Parent-Child Assistance Program, University of Washington.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Amy Salmon, Managing Director, Canada Northwest FASD Research Network; Clinical Assistant Professor, School of Population and Public Health, Faculty of Medicine, University of British Columbia.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Frank Oberklaid, Director, Centre for Community Child Health, Royal Children's Hospital, and Professor, Pediatrics, University of Melbourne.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Ms. Audrey McFarlane, Executive Director, Lakeland Centre for Fetal Alcohol Spectrum Disorder.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Elizabeth Bredberg, Education Consultant, Bredberg Research and Consulting in Education.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Claire Coles, Professor, Department of Psychiatry and Behavioral Sciences and Pediatrics, Emory University School of Medicine; Director, Fetal Alcohol and Drug Exposure Clinic, Marcus Autism Center, Children's Health Care of Atlanta.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Ms. Brenda Bennett, Executive Director, FASD Life's Journey Inc.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Prof. Sharon Brintnell, Professor, Department of Occupational Therapy, and Director, Occupational Performance Analysis Unit, Faculty of Rehabilitation Medicine, University of Alberta.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. John McLennan, Assistant Professor and Child Psychiatry Consultant, Departments of Community Health Sciences, Psychiatry, and Paediatrics, University of Calgary.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by the Honourable Mary Kate Harvie, Associate Chief Judge, Provincial Court of Manitoba.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Dorothy Badry, Assistant Professor, Faculty of Social Work, University of Calgary.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Sterling Clarren, CEO and Scientific Director, Canada Northwest FASD Research Network; Clinical Professor of Pediatrics, Faculty of Medicine, University of British Columbia; Clinical Professor of Pediatrics, University of Washington School of Medicine. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the…
PDF of a PowerPoint presentation by Dr. Sara Jo Nixon, Professor, Department of Psychiatry, University of Florida, Clinical and Translational Science Institute, Biobehavioral Core.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Gail Andrew, Member, Board of Directors, Canada Northwest FASD Research Network; Medical Site Lead - Pediatrics, Medical Director - FASD Clinical Services and Pediatric Consultant, Pediatric Programs, Glenrose Rehabilitation Hospital.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Suzanne Tough, Scientific Director, Alberta Centre for Child, Family and Community Research.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Philip May, Professor of Sociology and Family and Community Medicine, University of New Mexico; Senior Research Scientist, Center on Alcoholism, Substance Abuse, and Addictions.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Ben Gibbard, Developmental Pediatrician, Alberta Children's Hospital; Assistant Professor, Department of Pediatrics, Faculty of Medicine, University of Calgary.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Susan Astley, Professor of Epidemiology/Pediatrics, University of Washington; Director, Washington State Fetal Alcohol Syndrome Diagnostic and Prevention Network.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Albert Chudley, Medical Director, Winnipeg Regional Health Authority Program in Genetics and Metabolism; Professor, Department of Pediatrics, University of Manitoba.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Joanne Weinberg, Professor and Distinguished University Scholar and Acting Department Head, Cellular and Physiological Sciences, University of British Columbia.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Phil Jacobs, Professor, Gastroenterology Division, Department of Medicine, University of Alberta; Director of Collaborations, Institute of Health Economics.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Ms. Mary Berube, Director, Intergovernmental Initiatives, Ministry Support Services Division, Alberta Children and Youth Services.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Linda Burnside, Executive Director, Disability Programs, Manitoba Family Services and Housing.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Mr. Dan Dubovsky, FASD Specialist for the Substance Abuse and Mental Health Services Administration (SAMHSA), FASD Center for Excellence.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Ms. Diane Malbin, Executive Director, Fetal Alcohol Syndrome Consultation, Education and Training Services.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Ms. Robin Thurmeier, FASD Resources Researcher, Saskatchewan Prevention Institute.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. June Bergman, Associate Professor, Department of Family Medicine, Faculty of Medicine and Dentistry, University of Calgary.
Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
Alcohol can hurt the brain and body of an unborn baby and cause Fetal Alcohol Spectrum Disorder (FASD), a serious lifelong condition that impacts both the individual and their family. A child with FASD becomes an adult with FASD, facing birth defects, developmental and learning delays and social, educational, and employment challenges. The IHE Consensus Development Conference on…
Written by health policy experts, the book gives a comprehensive overview of 8 different national health care systems and focuses in particular on the different approaches to maintain efficiency and to contain overall healthcare costs. Each chapter identifies the 4-5 specific policies with the highest impact for the respective country over the past 20-30 years and the current policy…
PDF of a PowerPoint presentation by Dr. Stephen Duckett, President and CEO, Alberta Health Services.
IHE Innovation Forum II - Making Difficult Decisions
The Institute of Health Economics (IHE) Innovation Forum series reflects one of the key goals of the Institute to promote open debate and dialogue on important issues in the health care system among academia, government, health service executives and industry. The Institute believes that the significant challenges facing the health system will only be addressed if all partners…
PDF of a PowerPoint presentation by Sir Michael Rawlins, Chairman of National Institute of Clinical Excellence, UK.
IHE Innovation Forum II - Making Difficult Decisions
PDF of a PowerPoint presentation by Mr. Gregg Szabo, Executive Director, Policy, Reimbursement & Communicationa, Merck Frosst Canada Ltd.
IHE Innovation Forum II - Making Difficult Decisions
The objective of this report is to assess research evidence on the safety and prognostic value of exercise testing (including electrocardiogram exercise testing and cardiopulmonary exercise testing) for the prediction of cardiac events in patients with chronic diseases including diabetes, chronic obstructive pulmonary disease (COPD), and arthritis. Information Specialist: Trish…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is about testing for Human Papillomavirus (HPV). HPV is one of the most common sexually transmitted infections and can also cause cervical cancer. Cervical screening aims to reduce cervical cancer incidence and mortality by detecting precancerous lesions early. Until…
Les estimations indiquent que un canadien sur trois aura un problème de santé mentale durant sa vie. Peu de canadiens réalisent l’impact que la mauvaise santé mentale a sur les familles, les communautés, les systèmes de santé et l’économie. La santé mentale est aussi importante que la santé physique…
| Charles Yan, JoAnn Kingston-Riechers, Anderson Chuck
This report provides information regarding the impact of physician reimbursement models on five dimensions specified in the Provincial Alternate Relationship Plan Program Evaluation. The impact of physician reimbursement models were assessed on the following five dimensions: Health service utilization Access to care Quality of services Patient satisfaction Physician satisfaction…
The use of the term “comparative effectiveness” (CE) has attracted considerable attention, particularly in the United States. This booklet examines the concept of CE and its relationship to other assessment frameworks.
Background: Although many programs targeting fetal alcohol spectrum disorder (FASD) are implemented, the province of Alberta is still lacking information on costs of FASD.
Objectives: To estimate the costs of FASD in Alberta based on available US and Canadian research on costs of FASD, and Alberta data.
| Lisa Bergerman, Paula Corabian, Christa Harstall
The purpose of this report is to advance the area of workplace mental health through a comprehensive synthesis of published research evidence. More specifically, this report examines the evidence on the effectiveness of organizational-level interventions for the prevention of stress in the workplace for adult employees without diagnosed mental illness. The main effectiveness outcomes…
This report on assisted reproductive technologies (ARTs) is a literature review and secondary analyses of administrative health data conducted to provide information on the direct health care costs associated with multiple pregnancies and the potential cost impact of ARTs in Alberta. It examines the impact of multiple pregnancies and Assistive Reproductive Technologies on health…
The Institute of Health Economics sponsored Dr. Arne Ohlsson and Dr. Prakeshkumar Shah to write this book to inform the May 2007 Consensus Development Conference on Healthy Mothers Healthy Babies: How to Prevent Low Birth Weight. The book provides a synopsis of the research evidence on the determinants and prevention of preterm/low birth weight births. This book is a synopsis (an…
In December 2008, the Institute of Health Economics launched a series of semi-annual innovation forums whose goal is to bring together senior public and private sector decision-makers to address policy issues of importance in the health care system, not just in Alberta, but to all of Canada and the international community, as well. Emceed by Andy Greenshaw, Associate Vice President…
PDF of a PowerPoint presentation by Dr. Stuart McLeod, VP, Provincial Health Services Authority, British Columbia.
IHE Innovation Forum I - Paying for What Works
The purpose of this report is to update an earlier HTA report published in 2003. This report examines the newly published clinical research evidence on the safety and efficacy/effectiveness of islet transplantation in type 1 diabetic patients who have severe hypoglycemia episodes or hyperglycemia unawareness but are without kidney failure. The main clinical efficacy/effectiveness…
Canadian Health – Special Educational Supplement
In one way or another, depression will eventually touch us all. Whether you are a friend, colleague or caregiver of a person diagnosed with depression, you are likely aware of the often debilitating impact this condition can have on people’s lives.
Santé Canadien– Dossier d’Information Complémentaire Chacun d’entre nous sera, un jour ou l’autre, touché de près ou de loin par la dépression. Que vous soyez l’ami, le collègue de travail ou l’aidant naturel d’une personne atteinte de dépression, vous êtes probablement au courant des…
This report presents summary information on computed tomography (CT) and magnetic resonance imaging (MRI) in Alberta, with comparison to the use of these diagnostic imaging technologies in other jurisdictions. The aims of the report are to: illustrate the capacity in Alberta to diagnose and manage health problems with the help of these important technolgies compare the numbers,…
| Arto Ohinmaa, Carolyn Dewa, Trish Chatterley, Philip Jacobs
The mental health economics literature review shows that about one third of the articles found in the search did not include any or just minimal economic information. The database of 4005 references can be used to analyze the mental health economic literature e.g. by diagnosis, type of economic analysis, treatment, publication year, and targeted population.
L’honorable Michael Kirby (président de la Commission de la santé mentale du Canada) a présidé un éminent panel de citoyens et d’experts pour formuler des recommandations pratiques sur la façon d’améliorer la prévention, le diagnostic et le traitement des troubles dépressifs chez…
The Consensus Statement on Depression in Adults: How to Improve Prevention, Diagnosis and Treatment was produced by a panel of experts led by the Hon. Michael Kirby Chair, Mental Health Commission of Canada. This consensus statement was prepared by an independent panel of health professionals, academics, and public representatives based on: presentations by and questioning of experts…
PDF of a PowerPoint presentation by Dr. Harold A. Sackeim, Professor, Departments of Psychiatry and Radiology, College of Physicians and Surgeons of Columbia University; Emeritus Chief, Department of Biological Psychiatry, New York State Psychiatric Institute.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Raymond W. Lam, Professor and Head of the Division of Clinical Neuroscience, Department of Psychiatry, University of British Columbia; Director, Mood Disorders Centre of Excellence, University of British Columbia Hospital, Vancouver. Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Patrick Corrigan, Professor and Associate Dean for Research, Institute of Psychology, Illinois Institute of Technology.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Thomas Ungar, Chief of Psychiatry, North York General Hospital.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. David J. A. Dozois, Associate Professor, Department of Psychology, Faculty of Social Science, University of Western Ontario.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Glen Baker, Professor and Vice-Chair (Research) and Director, Neurochemical Research Unit, Department of Psychiatry, University of Alberta.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Sidney H. Kennedy, Professor of Psychiatry and Psychiatrist-in-Chief, University Health Network, University of Toronto; Founding Chair, Canadian Network for Mood and Anxiety Treatments (CANMAT).
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Scott B. Patten, Professor, Faculty of Medicine, Departments of Community Health Sciences and Psychiatry, University of Calgary.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Angus H. Thompson, Department of Psychiatry and Alberta Centre for Injury Control & Research, University of Alberta; Research Associate, Institute of Health Economics.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Scott B. Patten, Professor, Faculty of Medicine, Departments of Community Health Sciences and Psychiatry, University of Calgary.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Eldon R. Smith, Emeritus Professor, University of Calgary; Chair, Canadian Heart Health Strategy and Action Plan.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Ms. Lauren Brown BScPharm MSc ACPR, PhD Candidate, School of Public Health, University of Alberta.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Ms. Zorianna Hyworon, Chief Executive Officer, InfoTech Inc.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Philip Jacobs, Director, Research Collaborations, Institute of Health Economics; Professor, Health Economics, Faculty of Medicine, University of Alberta.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Sidney H. Kennedy, Professor of Psychiatry and Psychiatrist-in-Chief, University Health Network, University of Toronto; Founding Chair, Canadian Network for Mood and Anxiety Treatments (CANMAT).
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Vincent Felitti, Clinical Professor of Medicine, University of California; Founding Chair of Preventative Medicine, Kaiser Permanente, San Diego.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Nady el-Guebaly, Professor and Head, Addiction Division, Department of Psychiatry, University of Calgary; Medical Director, Addiction Program & Centre, Alberta Health Services/Calgary Health Region.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. David L. Streiner, Professor, Department of Psychiatry, University of Toronto; Assistant Vice President, Research Director, Kunin-Lunenfeld Applied Research Unit, Baycrest.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. June Bergman, Associate Professor, Department of Family Medicine, University of Calgary.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Raymond W. Lam, Professor and Head of the Division of Clinical Neuroscience, Department of Psychiatry, University of British Columbia; Director, Mood Disorders Centre of Excellence, University of British Columbia Hospital, Vancouver. Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Keith Dobson, Professor and Head of the Department of Psychology, University of Calgary; Executive Director, Council of Canadian Departments of Psychology; President-Elect, Academy of Cognitive Therapy; President-Elect, International Association of Cognitive Psychotherapy. Consensus Development Conference on Depression in Adults: How…
PDF of a PowerPoint presentation by Dr. Janet M. de Groot, Associate Professor, Departments of Psychiatry and Oncology and Associate Dean, Equity and Teacher-Learner Relations, University of Calgary.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
PDF of a PowerPoint presentation by Dr. Dan Bilsker, Adjunct Professor, Faculty of Health Sciences, Simon Fraser University; Clinical Assistant Professor, Faculty of Medicine, University of British Columbia.
Consensus Development Conference on Depression in Adults: How to Improve Prevention, Diagnosis, and Treatment
The Institute of Health Economics (IHE), in collaboration with the Alberta Depression Initiative Project, Alberta Health and Wellness, the Alberta Mental Health Board and the Mental Health Commission of Canada organized a Consensus development conference on Depression in Adults: How to Improve Prevention, Diagnosis and Treatment in Calgary, Alberta in October 2008. The main objective…
How much should we spend on mental health? provides an overview of the various approaches that have been used to answer the question of health spending, applied to the mental health context. Estimates using several of the approaches are provided.
Information Specialists: Trish Chatterley, Liz Dennett
Discussing all aspects of chronic pain management, this is the second volume of the new book series on health care and disease management, published with the Institute of Health Economics (IHE) in Edmonton, Canada. The authors provide an introduction into the history, pathophysiology, ethics and epidemiology of chronic pain before covering the different aspects of treating chronic…
The Importance of Measuring Health Related Quality of Life report provides an overview of health-related quality of life (HRQL) measurement to facilitate and understanding of such measures to be used in both clinical practice and research. Health-related quality of life (HRQL) measures have been widely used in health research in recent years and have been the endpoint in many clinical…
IHE In Your Pocket (IHE IYP) presents a bird’s eye view of the economic aspects of the Canadian healthcare system with international comparisons. IHE IYP 2008 has been reorganized and expanded, and includes the most currently available data. Topics are presented related to resources first, addressing in turn economic burden of illness, expenditures, physical resources, prices,…
| David Hailey, Jeremy Grimshaw, Martin Eccles, Craig Mitton, Carol E. Adair, Emily McKenzie, Scott Patten, Brenda Waye-Perry, Leif Rentzhog, Paul Taenzer, Christa Harstall, Saifee Rashiq, Pamela Barton, Don Schopflocher, Lynda Jobin
Effective Dissemination of Findings from Research contains essays resulting from a workshop on effective dissemination of findings from research organized by the Institute of Health Economics. The publication is intended as one of the many available resources on dissemination of research findings for those interested in the subject. Chapter 3 of this report originally appeared…
| Ann Scott, Carmen Moga, Christa Harstall, Jacques Magnan
Abstract: Health technology assessments (HTAs) are an as yet unexploited source of comprehensive, systematically generated information that could be used by research funding agencies to formulate researchable questions that are relevant to decision-makers. We describe a process that was developed for distilling evidence gaps identified in HTAs into researchable questions…
This rapid assessment addressed a request to assess the published research evidence on how the Actim™ Partus test compares to the TliIQ® System in terms of diagnostic accuracy, clinical utility, and costs when added to preterm labour management in symptomatic women with intact membranes.
Air ambulance transportation with capabilities to provide advanced life support. The objective of this report is to present and synthesize the available published research evidence on the efficacy/effectiveness, safety, and efficiency of air ambulance transportation (helicopters) with on-board capabilities of advanced life support (ALS). The intent is to use this evidence to inform…
Discussing issues of health care financing, this is the first volume in a completely new public health book series, edited by the Institute of Health Economics (IHE) in Alberta, Canada. Starting with various funding methods, it also features sections on different health care payment and purchasing mechanisms, as well as equity issues. This book is of interest to medical and allied…
Risk assessment tools for predicting recidivism of spousal violence. The objective of this report is to assess the research evidence on the inter-rater reliability and predictive validity of various risk assessment instruments in predicting male-to-female spousal violence recidivism and lethality in those males who had contact with the police system. Information Specialist: Liz…
The role of rapid fetal fibronectin assay in the management of spontaneous preterm labour The objective of this report is to evaluate the added value of using fetal fibronectin (Rapid fFN for the TLi™ System, referred to here as the rapid fFN assay) to diagnose spontaneous preterm labour (PTL) in symptomatic women, which is the only fFN detection modality currently available…
This report compares the use of telemental health services in Canada and Finland, focusing specifically on the use of videoconferencing.
Information Specialist: Janice Varney
Evidence of benefit from telemental health applications: a systematic review.
This review considers the evidence of benefit from use of telemental health (TMH) in studies that had clinical, economic, or administrative outcomes. The review also includes studies that provided information on the accuracy or feasibility of TMH.
Information Specialist: Janice Varney
This booklet brings together information that demonstrates the burden of mental illness and where Canada’s mental health system ranks among other developed countries. It also provides important consolidated information on key indicators that depict the state of our mental health system.
| Ann Scott, Carmen Moga, Pamela Barton, Saifee Rashiq, Don Schopflocher, Paul Taenzer, Christa Harstall
Rationale and objective: A research translation strategy for chronic pain was developed that has significant potential to advance the usefulness of systematic reviews (SRs) in clinical practice.
Note: This is an Alberta Ambassador Guideline Adaptation Program related publication.
The Alberta Diabetes Surveillance System (ADSS) was created in 2006 in a partnership between Alberta Health and Wellness (AHW) and the Institute of Health Economics (IHE). The purpose of the ADSS is to provide information on diabetes in the province of Alberta. This information includes the incidence, prevalence and use of health care services for people with diabetes, along with…
World In Your Pocket - A Handbook of International Health Economic Statistics includes the most current available data, presented in separate sections on health status, health care costs, health resources, health resources, health resource utilization, and health system performance.
This consensus statement on how to prevent low birth weight was developed to inform patients, health policy, and practice. It is a product of the IHE Consensus Development Conference on Healthy Mothers - Healthy Babies: How to Prevent Low Birth Weight held April 23 to 25, 2007
| Philip Jacobs, Rita Yim, Arto Ohinmaa, Janice Varney, Anita Hanrahan, Joy Loewen, Laura Mashinter, Bev Baptiste, Margaret Russell
This booklet is a compendium of existing statistics related to the economic aspect of childhood immunizations in Canada. It brings together, in one document, data obtained from a wide range of sources. It covers topics related to the economic and epidemiological burden of childhood diseases, resources used, and system performance from provincial, national, and international viewpoints.
Routine Preoperative Tests - Are They Necessary? is about routine preoperative testing on otherwise healthy patients who are scheduled for elective surgery. This report is a synopsis of the findings from some of the major health technology assessments and systematic reviews on preoperative testing published during the last two decades. The implications of these results for Alberta…
The Institute of Health Economics (IHE) co-hosted this Calgary conference in April 2007 to consult experts on factors contributing to the low birth weight rate in Alberta, to develop a consensus on the relevant factors, and to tailor interventions to address the contributing factors. The consensus statement on how to prevent low birth weight was developed to inform patients, health…
Safety and efficacy of inhaled nitric oxide in the management of hypoxemic respiratory failure in adults with acute respiratory distress syndrome. This report was prepared in collaboration with the Health Technology Assessment program of the Institute of Health Economics, SEARCH Canada, and Calgary Health Region. It focuses on the published scientific evidence regarding the safety…
| Anderson Chuck, Philip Jacobs, Thanh Nguyen, Arto Ohinmaa, Janice Varney
Evaluation of enzyme immunoassay and immunoblot testing for the diagnosis of syphilis in Alberta. A new protocol for testing and diagnosing syphilis has been proposed in Alberta. The protocol proposes replacing rapid plasma reagin (RPR) with enzyme immunoassay (EIA) as the standard initial test and replacing Treponema pallidum (T. pallidum) particle agglutination assay (TPPA) and…
A successful screening program for cystic fibrosis (CF) refers to the ability of the program to appropriately identify and refer for care those with CF, while meeting the needs of those who do not have CF, particularly those infants identified by the screening program as carriers (individuals unaffected by CF but have a mutation in one of their CFTR genes). Some measures of success…
The use of the automated auditory brainstem response and otoacoustic emissions tests for newborn hearing screening. Permanent congenital hearing impairment/loss (PCHI) is one of the most common congenital anomalies found at birth which can be expected to lead to delays and deficits in the development of speech, language, cognition and learning, as well as secondary effects on the…
| David Hailey, Marie-Josée Paquin, Olga Maciejewski, Linda Harris, Ann Casebeer, Gordon Fick, Patti Taschuk, Anthony Fields
Teleoncology: Applications and associated benefits for the adult population. This report determines the current state of evidence on teleoncology applications to improve access to care closer to home for rural patients and families affected by a diagnosis of cancer. It follows an earlier report by Marie-Josée Paquin prepared as part of her participation in the SEARCH Classic…
The objective of this statement was to develop a consensus statement on the benefits and costs of testing supplies for self-monitoring of blood glucose in diabetes, to inform patients, health policy and practice.
This Mental Health Economic Statistics booklet brings together information that demonstrates the burden of mental illness and where Canada’s mental health system ranks among other developed countries. Mental Health Economic Statistics provides important consolidated information on key indicators that depict the state of our mental health system. NOTE: In 2006 the Alberta…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #24. Health technology assessments (HTAs) routinely identify questions or research ‘gaps’ that are not adequately addressed by the primary research. The unique situation of having an HTA unit housed within a provincial research funding organization provided an ideal setting for linking research…
Institute of Health Economics Working Paper WP 06-02. The purpose of this report is to examine the economic implications for the province if a supplement to the fee schedule were allowed for vacuum-assisted biopsies. NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents produced in and prior to 2006 have different formats; the format…
| Philip Jacobs, Arto Ohinmaa, Scott Klarenbach, Anderson Chuck, Raj Padwal, Janice Varney, Doug Lier
Institute of Health Economics Working Paper WP 06-01. The purpose of this report is to examine the economic issues associated with LGB. The following analyses were conducted: a systematic review of the economic literature on obesity-related interventions, with special attention to the differences between gastric bypass and gastric banding; an estimate of the Alberta population…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #20. Health Technology Assessment (HTA) is the systematic evaluation of properties, effects and/or other impacts of health care technology. Its primary purpose is to provide objective information to support health care decisions and policy making at the local, regional, national and international levels. NOTE:…
| Saifee Rashiq, Pamela Barton, Christa Harstall, Don Schopflocher, Paul Taenzer
Background: The purpose of Health Technology Assessment (HTA) is to make the best possible summary of the evidence regarding specific health interventions in order to influence health care and policy decisions. The need for decision makers to find relevant HTA data when it is needed is a barrier to its usefulness. These barriers are highest in rural areas and amongst isolated…
| Sheri Pohar, Sumit Majumdar, Philip Jacobs, Jeffrey Johnson
Institute of Health Economics Working Paper WP 06-04. The purpose of this analysis was to compare health care utilization as well as costs and mortality of individuals with diabetes in the province of Saskatchewan from 1999 to 2001, according to residential location. NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents produced in…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #38. This report aims to identify strategies that have been evaluated and reported in the literature and to assess their effectiveness in reducing emergency department overcrowding. Information Specialists: Seana Collins, Liz Dennett NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved…
| Margaret Wanke, Don Juzwishin, Richard Thornley, Liza Chan
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #16. The objectives of this review were: To propose a generic evaluation framework for HTA agencies to strengthen their evaluation capacity. To conduct a review of HTA agencies to understand what aspects of HTA agencies have been evaluated, approaches/methods used, outcomes of hte evaluations and to understand…
This is the first edition of IHE In Your Pocket. This chart book is designed to be an easy reference guide to indicators of Canadian health care economic performance. Economic is broadly defined to include both means (personal and formal resources) and ends (health outcomes). The chart book is intended to provide the user with a concise, accessible, and reasonably comprehensive…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #37. The aim of this paper is to present the current evidence on the efficacy/effectiveness, safety, and efficiency of gastric electrical stimulation (EnterraTM Therapy System) used for the treatment of patients with severe gastroparesis (GP). Information Specialist: Liz Dennett NOTE: In 2006 the Alberta Heritage…
| David Cooke, Meina Dubetz, Rahim Heshmati, Sandra Iftody, Erin McKimmon, Jodi Powers, Robert Lee, Peter Dunscombe
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #22. We present a model process that will assist health care organizations in developing and implementing a formal management system for learning from incidens. Developed specifically for the Radiation Treatment (RT) Program at the Tom Baker Cancer Centre, a major cancer treatment centre in Calgary, Alberta,…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #23. This report is intended as a discussion primer for two challenges increasingly faced by health technology assessment (HTA), health impact assessment (HIA), health needs assessment, parliamentary technology assessment (PTA), participatory technology assessment, policy makers in numerous areas, health care…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #21. Much of the activity and purpose of HTA is related to interaction with organizations and individuals with interests in the technologies that are being considered. The focus is often stakeholders with major financial or operational responsbilities for health technologies, including government authorities,…
Institute of Health Economics Working Paper WP 05-07. The aim of this paper is to compare health in Canada and the United States using a preference-based measure. NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents produced in and prior to 2006 have different formats; the format was determined by the agency for which the document…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #36. The objective of this report is to identify the most appropriate investigative protocol, or component of a protocol, for determining the cause(s) of stillbirth and to identify protocols that have been recommended by health authorities and professional associations both within Canada and worldwide. Information…
Institute of Health Economics Working Paper WP 05-03. Missing data is a common problem in studies that collect data on patient-reported outcomes data. This paper reports the methods, results, and an evaluation of one method for imputing missince Centre for Epidemiological Studies-Depression (CES-D) data in a study of health-related quality of life (HRQL) in a cohort of patients…
| Sheri Pohar, Scot Simpson, Sumit Majumdar, Philip Jacobs, Arto Ohinmaa, William Osei, Mary Rose Stang, Winanne Downey, Jeffrey Johnson
Institute of Health Economics Working Paper WP 05-06. The purpose of this study was to analyze epidemiologic and cost trends from 1991 to 2001 in the province of Saskatchewan for a cohort of individuals identified as having diabetes and for a randomly selected control cohort. The objectives were to: explore epidemiologic trends (i.e., prevalence, incidence and mortality) in diabetes…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #18. This paper has two specific objectives: to describe some of the challenges of using research evidence to inform healthcare policy making; and to provide policy makers and researchers with a framework or tool that would identify and facilitate the use of research evidence and other information in healthcare…
| Sheri Maddigan, David Feeny, Sumit Majumdar, Karen Farris, Jeffrey Johnson
Institute of Health Economics Working Paper WP 05-02. The purpose of this report was to assess the cross-sectional construct validity of the Health Utilities Mark 3 (HUI3) in type 2 diabetes using population-health survey data. NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents produced in and prior to 2006 have different formats;…
| Anita Simon, Robert Lee, David Cooke, Diane Lorenzetti
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #17. This paper focuses on incident reporting systems relevant to the hospital and efforts to improve patient safety and clinical outcomes. Costs associated with incident reporting systems are included wherever possible. This paper aims to assess the effectiveness of hospital incident reporting systems in improving…
Alberta Heritage Foundation for Medical Research (AHFMR) Information Paper #26. The aim of this study was to determine whether laparoscopic adjustable gastric banding (LAGB) is a safe and effective procedure compared with open and/or laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic vertical banded gastroplasty (LVBG), especially in the longer term (> or = five…
Alberta Heritage Foundation for Medical Research (AHFMR) Information Paper #25. The aim of this report is to provide a cost estimate, over a one year time period from a payer’s perspective, of Biosite Triage Point-of-Care (POC) B-Type Natriuretic Peptide (BNP) assay used to rule out congestive heart failure (CHF) from other pulmonary conditions for patients presenting in…
| Sheri Maddigan, David Feeny, Sumit Majumdar, Karen Farris, Jeffrey Johnson
Institute of Health Economics Working Paper WP 05-01. The objective of this paper is to assess a broad range of determinants of health to determine which are most strongly associated with health-related quality of life (HRQL) in people with type 2 diabetes. NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents produced in and prior…
Alberta Heritage Foundation for Medical Research (AHFMR) Information Paper #24. The objective of this paper is to present the current evidence on the efficacy/effectiveness and safety of celeoxib (Celebrex®) for the treatment of pain in patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Information Specialist: Seana Collins NOTE: In 2006 the Alberta Heritage Foundation…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #19. The intent is to develop an overview as a guide to HTA managers; this paper should be regarded as a vehicle for further discussion on these issues. NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents produced in and prior to 2006 have different formats; the…
Alberta Heritage Foundation for Medical Research (AHFMR) Information Paper #23. The activities of the HTA Unit in 2002–2003, as reflected in various types of reports it had produced and related dissemination activities, were reviewed in a paper published in 2004. The paper provided an overview of the effectiveness of the Unit as an aid to its future management, drawing on…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #35. The objective of this report is to assess the efficacy and safety of using trigger point injection (TPI) to treat patients with chronic non-malignant musculoskeletal pain, based on a systematic review of the current published evidence, and to determine the current state of the procedure, the feasibility of…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #34. This report reviews the literature on assessment of telecardiology, considering applications in pediatric care, hospital or clinic use for adults, emergency care, and home care. Information Specialist: Seana Collins NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents…
| Robert Lee, Karie-Lynn Kelly, Chris Newcomb, David Cooke, Edidiong Ekaette, Peter Craighead, Peter Dunscombe
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #15. This paper summarizes the first steps in a research program designed to inform technology assessment and decision-making associated with radiotherapy (treatment of cancer with ionizing radiation) at the Tom Baker Cancer Centre (TBCC) in Calgary, Alberta. NOTE: In 2006 the Alberta Heritage Foundation for…
Alberta Heritage Foundation for Medical Research (AHFMR) Information Paper #21. The objective of this report is to evaluate the published evidence on the safety, efficacy, and current status of living donor liver transplantation for the treatment of end stage liver disease in children. Information Specialist: Leigh-Ann Topfer NOTE: In 2006 the Alberta Heritage Foundation for Medical…
Alberta Heritage Foundation for Medical Research (AHFMR) Information Paper #19. The objective of this report was to conduct a systematic review of the published research on the use of sclerotherapy to manage varicose veins of the legs. The intent of this paper was to answer the following questions: Is sclerotherapy effective for varicose veins of the legs and if so, is one approach…
| Leanne Kmet, Robert Lee, Linda Cook, Diane Lorenzetti, Glenys Godlovitch, Edna Einsiedel
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report. In this systematic review, we have critically reviewed the literature addressing the social, legal and ethical issues related to genetic testing for cancer susceptibility, synthesized current information and identified existing gaps in knowledge. We believe the review will prove valuable to policy- and decision-makers…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #33. This report is a systematic review and critical appraisal of the evidence on the use of ovulation induction (OI) drug therapy to manage anovulatory infertility associated with polycystic ovary syndrome (PCOS) in women of reproductive age. The aim was to provide the current published scientific evidence about…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #13. Appraising the quality of evidence is an important, yet difficult task, complicated by the consideration of disparate evidence. Quality checklists for assessing RCTs abound, yet it is acknowledged that even within this single study the reliability, validity, feasibility and utility of the various tools…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #32. The aim of this report was to critically appraise and synthesise the published evidence regarding the short- and long-term efficacy/effectiveness of surgical techniques for patients with deep venous incompetence, and attendant skin changes/ulceration, that is refractory to standard care. Information Specialist:…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #31. This report was prepared in response to a request from Alberta Health and Wellness (AHW) for information about the use of islet cell transplantation for patients with type 1 diabetes. AHW was specifically interested in the current status of islet cell transplantation using the Edmonton protocol for a sub-population…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #28. This report provides an overview of the evidence from systematic reviews on the effectiveness of suicide prevention strategies. NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents produced in and prior to 2006 have different formats; the format was determined…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #30. Using the 1996 National Population Health survey data, this report provides an estimate of the prevalence of chronic pain (CP) among Albertans. It was estimated that 11.2% of Albertans suffer some level of CP and about 2.3% suffer from severe CP. As the proportion of individuals suffering from CP increases…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #29. The aim of this report was to present and critically appraise the published evidence on the prevalence of chronic non-malignant pain in the general population and the primary care setting. A secondary objective was to summarize all the available information in the primary studies about characteristics of pain…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #27. This project is Part II of a request from several Regional Health Authorities and Alberta Health and Wellness, regarding two key objectives: to present information on the regulation of acupuncture in Alberta, including the scope of practice and coverage of services; and to conduct a systematic review of current…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #26. Given the very broad range of suicide prevention strategies, it is unrealistic to cover all of them in this report. Thus, the main focus of this review is to present the findings from primary research that assessed the efficacy/effectiveness of suicide prevention programs on school aged children and youth…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #25. This report is a systematic review of the literature on the use of computerized electrocardiogram (ECG) interpretation for detecting heart conditions as a part of routine medical examinations in healthy adults. The aim of this report is to inform practitioners and other interested parties on the available…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #24. This report has been produced in response to a request from Alberta Health and Wellness for an update on the use of vagus nerve stimulation (VNS) for refractory epilepsy. The intent was to inform health policy makers, medical practitioners, and the public on the current status of the use of VNS for refractory…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #23. This report is a systematic review and critical appraisal of the literature on the use of formal outpatient diabetes education as a therapeutic tool for self-management in adult patients with type 2 diatetes. It has been prepared to provide information to the Capital Health Authority in Alberta, Canada and…
| Sue Ludwig, Patricia Leggett Tait, Christa Harstall
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #22. This review was requested to determine whether conductive education as a learning approach or therapeutic intervention is safe and efficacious for children with disabilities such as cerebral palsy that impact neuromotor functioning. The review also addresses the profile of the child who would benefit from…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #21. The three objectives of this assessment are to determine the available scientific evidence on: the effective time interval for mammography screening in asymptomatic women aged 50 to 69 years; the effective screening interval in asymptomatic women between the ages of 40 and 49 years; and the mortality rate…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #18. This report has been prepared following interest by the Alberta Cord Blood Bank in obtaining advice on the comparative effectiveness and costs of different types of stem cell transplantation. Earlier assessments by the Foundation have considered peripheral blood stem cell transplantation and cord blood transplantation.…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #17. The present report has been prepared as a follow up to the previous assessment because of continued interest in the technology by the health ministry and others. It considers studies that have been reported in the literature since completion of the earlier assessment (1997-1999) and focuses on the efficacy…
| Jennifer Simpson, Sandra Doze, Douglas Urness, David Hailey, Philip Jacobs
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #20. This report presents data from the telepsychiatry program subsequent to the pilot project. The assessment of telepsychiatry beyond the pilot project stage had two primary focuses: a) to develop and document information collection systems initiated during the pilot project evaluation, and b) to assess the operation…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #19. A request for information about the use of low level laser therapy (LLLT) to assist wound healing was received from the Capital Health Authority (CHA). This technology has been increasingly used within the Edmonton area, with somewhat different approaches being taken by individual operators. The concern was…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #16. This report has been prepared in view of the continuing interest in positron emission tomography and other functional diagnostic imaging (FDI) methods within the Alberta health care system. It also continues the work at the Alberta Heritage Foundation for Medical Research in developing approaches to assessment…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #16. This is the second volume of an assessment of functional diagnostic imaging methods in imaging of the myocardium. Volume 1 included an overview of the assessment findings and provided comments on the place of the FDI techniques in this application. In this volume, further details are given of the assessment…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #15. The present health technology assessment report has been prepared following a request by Alberta Health and Wellness for additional information on the use of stereotactic radiosurgery (SRS) in the treatment of acoustic neuroma, one of the applications considered in an earlier publication on SRS. Two main issues…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #14. This report has been prepared because of the interest by the Consumers' Association of Canada and the Health Ministry in the increasing use of newer types of intraocular lenses (IOLs) and in their comparative advantage. The focus of the report is on the safety, efficacy and effectiveness of the three types…
| Maureen Yunkap Kwankam, David Hailey, Philip Jacobs
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #13. This assessment has been prepared in view of the interest at the University of Alberta Hospital in developing a cord blood banking facility in the province and to provide information to decision makers on the current status of cord blood transplantation (CBT). The principal purpose of the assessment was to…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #12. This report has been prepared following a request from the provincial Clinical Practice Guidelines Program for information on the accuracy of diagnostic tests for the detection of bacterial vaginosis (BV), vulvovaginal candidiasis (VVC) and trichomoniasis in females of reproductive age. The intention of this…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #11. This report has been prepared in view of the increasing interest in ultrasound technology for diagnosis of osteoporosis. Until recently, quantitative ultrasound (QUS) was mainly being used in research settings. This procedure is still not covered by provincial fee schedules. The recent FDA pre-marketing approvals…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #10. This report has been prepared as part of a project to assess the role of high cost functional diagnostic imaging (FDI) and related methods in routine health care. In the present paper, the potential application of four FDI methods to the management of epilepsy is considered. The assessment considered the current…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #8. This report has been prepared to provide information to health authorities and others on the available evidence on effectiveness of HBOT and the possible economic impact on health care should a second HBO facility be established in the province. Issues addressed in the report include: Whether HBOT has been…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #9. The present report has been prepared following a request by Alberta Health in relation to referral of patients outside the province for treatment with stereotactic radiosurgery (SRS). There was interest by the department in the comparative effectiveness of the two main approaches to SRS (GK and LINAC) and in…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #7. This assessment was undertaken at the request of a Regional Health Authority to provide input into a funding decision on a computerized dynamic posturography (CDP) system for use by a rehabilitation department. The focus of this study was restricted to the clinical use of CDP by the rehabilitation community.…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #6. This report provides details of a telepsychiatry pilot project undertaken by the Provincial Mental Health Advisory Board-Central Alberta (PMHAB) in cooperation with four Regional Health Authorities. It supplements an earlier report issued by the Board describing the pilot project evaluation and has been prepared…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #5. This assessment of computerized gait analysis in the management of children with cerebral palsy (CP) or spina bifida (SB) has been prepared at the request of the Glenrose Hospital, Edmonton. The hospital has already undertaken developmental work towards establishing a gait analysis facility. Advice was sought…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #4. This outline of issues in the assessment of telehealth is intended as a resource document for health care funders, providers and administrators. Health authorities and others in Alberta face decisions on the procurement and use of this information and communication technology. Such decisions should be informed…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #3. The intent of this report is to inform medical practitioners and the public on the current status of in vitro fertilization and embryo transfer (IVF-ET) as a treatment for various types of infertility, and on its use and coverage in Canada. The report has been prepared because of the interest and debate regarding…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #2. This paper is intended as a short overview of the effectiveness and status of a neurosurgical procedure, posteroventral pallidotomy (PVP), which is used in the treatment of some people with Parkinson's Disease. NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #1. This report has been prepared to provide information and assist discussion on the management of pressure sores, a significant source of morbidity in health care institutions. The focus of the report is on a specific technology, interface pressure measurement. It is expected that other issues in this are will…